UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
(Amendment No. )
Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐
Check the appropriate box:
☐ | Preliminary Proxy Statement |
☐ | Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
☒ | Definitive Proxy Statement |
☐ | Definitive Additional Materials |
☐ | Soliciting Material Pursuant to §240.14a-12 |
CBRE Group, Inc.
(Name of Registrant as Specified in Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
☒ | No fee required. |
☐ | Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. |
1. | Title of each class of securities to which transaction applies:
| |||
2. |
Aggregate number of securities to which transaction applies:
| |||
3. |
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
| |||
4. |
Proposed maximum aggregate value of transaction:
| |||
5. |
Total fee paid:
|
☐ | Fee paid previously with preliminary materials. |
☐ | Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. |
1. |
Amount Previously Paid:
| |||
2. |
Form, Schedule or Registration Statement No.:
| |||
3. |
Filing Party:
| |||
4. |
Date Filed:
|
400 South Hope Street, 25th Floor
Los Angeles, California 90071
(213) 613-3333
April 5, 2018
Dear Fellow Stockholder:
On behalf of the Board of Directors and management of CBRE Group, Inc., I cordially invite you to attend our annual meeting of stockholders on Friday, May 18, 2018, at 200 Park Avenue, 21st Floor, New York, New York at 8:30 a.m. (Eastern Time). The notice of meeting and proxy statement that follow describe the business that we will consider at the meeting.
We hope that you will be able to attend the meeting. However, regardless of whether you are present in person, your vote is very important. We are pleased to again offer multiple options for voting your shares. You may vote by telephone, via the internet, by mail or in person, as described beginning on page 1 of the proxy statement.
Thank you for your continued support of CBRE Group, Inc.
Sincerely yours,
Robert E. Sulentic
President and Chief Executive Officer
Notice of 2018 Annual Meeting
of Stockholders
May 18, 2018
8:30 a.m. (Eastern Time)
200 Park Avenue, 21st Floor, New York, New York
AGENDA:
1. | Elect the 10 Board-nominated directors named in the Proxy Statement; |
2. | Ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2018; |
3. | Conduct an advisory vote on named executive officer compensation for the fiscal year ended December 31, 2017; |
4. | Approve an amendment to our certificate of incorporation to reduce (to 25%) the stock-ownership threshold required for our stockholders to request a special stockholder meeting; |
5. | If properly presented, to consider a stockholder proposal regarding our stockholders ability to call special stockholder meetings; and |
6. | Transact any other business properly introduced at the Annual Meeting. |
Only stockholders of record as of March 20, 2018 will be entitled to attend and vote at the Annual Meeting and any adjournments or postponements thereof.
We hope that you can attend the Annual Meeting in person. Regardless of whether you will attend in person, please complete and return your proxy so that your shares can be voted at the Annual Meeting in accordance with your instructions. Any stockholder attending the Annual Meeting may vote in person even if that stockholder returned a proxy. You will need to bring a picture ID and proof of ownership of CBRE Group, Inc. stock as of the record date to enter the Annual Meeting. If your common stock is held in the name of your broker, bank or other nominee and you want to vote in person, then you will need to obtain a legal proxy from the institution that holds your common stock indicating that you were the beneficial owner of our common stock on March 20, 2018.
We are pleased to furnish proxy materials to our stockholders on the internet. We believe that this allows us to provide you with the information that you need while lowering the costs of delivery and reducing the environmental impact of the Annual Meeting.
April 5, 2018
By Order of the Board of Directors
Laurence H. Midler
Executive Vice President, General Counsel and Secretary
This Proxy Statement and accompanying proxy card are first being made available on or about April 5, 2018.
References in this Proxy Statement to CBRE, the company, we, us or our refer to CBRE Group, Inc. and include all of its consolidated subsidiaries, unless otherwise indicated or the context requires otherwise. References to the Board refer to our Board of Directors. A copy of our Annual Report on Form 10-K for the fiscal year ended December 31, 2017, including financial statements, is being sent simultaneously with this Proxy Statement to each stockholder who requested paper copies of these materials and will also be available at www.proxyvote.com.
Proxy Summary Information
To assist you in reviewing the proposals to be voted upon at our 2018 Annual Meeting, we have summarized important information contained in this Proxy Statement and our Annual Report on Form 10-K for the fiscal year ended December 31, 2017. This summary does not contain all of the information that you should consider, and you should carefully read the entire Proxy Statement and Annual Report on Form 10-K before voting.
Voting
Stockholders of record as of March 20, 2018 may cast their votes in any of the following ways:
Internet | Phone | In Person | ||||
Visit www.proxyvote.com. You will need the 16-digit number included in your proxy card, voter instruction form or notice. | Call 1-800-690-6903 or the number on your voter instruction form. You will need the 16-digit number included in your proxy card, voter instruction form or notice. | Send your completed and signed proxy card or voter instruction form to the address on your proxy card or voter instruction form. | If you plan to attend the meeting, you will need to bring a picture ID and proof of ownership of CBRE Group, Inc. stock as of the record date. If your common stock is held in the name of your broker, bank or other nominee and you want to vote in person, then you will need to obtain a legal proxy from the institution that holds your common stock indicating that you were the beneficial owner of our common stock on March 20, 2018. |
Voting Matters and Board Recommendation
Proposal
|
Board Vote Recommendation
| |
Elect Directors (page 8)
|
ü FOR each Director Nominee
| |
Ratify the Appointment of Independent Registered Public Accounting Firm for 2018 (page 27)
|
ü FOR
| |
Advisory Vote to Approve Named Executive Officer Compensation for 2017 (page 30)
|
ü FOR
| |
Approve an Amendment to our Certificate of Incorporation to Reduce (to 25%) the Stock-Ownership Threshold Required for our Stockholders to Request a Special Stockholder Meeting (page 70)
|
ü FOR
| |
If Properly Presented, to Consider a Stockholder Proposal Regarding Special Stockholder Meetings (page 73)
|
✘ AGAINST
|
Fiscal Year 2017 Business Highlights(1)
(1) | For more complete information regarding our fiscal year 2017 performance, please review our Annual Report on Form 10-K for the fiscal year ended December 31, 2017. You can obtain a free copy of our Annual Report on Form 10-K at the SECs website (www.sec.gov) or by submitting a written request by (i) mail to CBRE Group, Inc., Attention: Investor Relations, 200 Park Avenue, New York, New York 10166, (ii) telephone at (212) 984-6515 or (iii) e-mail at investorrelations@cbre.com. |
CBRE - 2018 Proxy Statement | 1 |
PROXY SUMMARY INFORMATION
The following charts highlight our growth in adjusted EBITDA, adjusted net income and adjusted EPS for 2017 relative to 2016:
(2) | Fee revenue is gross revenue less both client reimbursed costs largely associated with employees that are dedicated to client facilities and subcontracted vendor work performed for clients. |
(3) | These are non-GAAP financial measures. For supplemental financial data and a corresponding reconciliation of (i) revenue computed in accordance with GAAP to fee revenue, (ii) net income computed in accordance with GAAP to adjusted EBITDA and (iii) net income computed in accordance with GAAP to adjusted net income and to adjusted EPS, in each case for the fiscal years ended December 31, 2017 and 2016, see Annex A to this Proxy Statement. We also refer to adjusted EBITDA, adjusted net income and adjusted EPS from time to time in our public reporting as EBITDA, as adjusted, net income attributable to CBRE Group, Inc., as adjusted and diluted income per share attributable to CBRE Group, Inc. shareholders, as adjusted, respectively. As described in our Annual Report on Form 10-K for the fiscal year ended December 31, 2017, our Board and management use non-GAAP financial measures to evaluate our performance and manage our operations. However, non-GAAP financial measures should be viewed in addition to, and not as an alternative for, financial results prepared in accordance with GAAP. The term GAAP, as used in this Proxy Statement, means generally accepted accounting principles in the United States. |
2 | CBRE - 2018 Proxy Statement |
ADJUSTED EBITDA $ in millions ADJUSTED NET INCOME $ in millions ADJUSTED EPS
PROXY SUMMARY INFORMATION
Our Corporate Strategy
Corporate Governance Highlights
Board Independence
| ||
Independent director nominees
|
9 out of 10
| |
Independent Chair of the Board
|
Ray Wirta*
| |
Director Elections
| ||
Frequency of Board elections
|
Annual
| |
Voting standard for uncontested elections
|
Majority Requirement
| |
Director term limits
|
12 Years(4)
| |
Limit on number of Board-nominated executive officers
|
Maximum 1
| |
Proxy access for director nominations
|
Yes
| |
Evaluating and Improving Board Performance
|
||
Board evaluations
|
Annual
| |
Committee evaluations
|
Annual
| |
Aligning Director and Executive Interests with Stockholder Interests
| ||
Director stock ownership requirements
|
Yes
| |
Executive officer stock ownership requirements
|
Yes
| |
Policy restricting trading, and prohibiting hedging and short-selling of, CBRE stock
|
Yes
| |
Compensation clawback policy for executive officers
|
Yes
| |
Ongoing stockholder outreach and engagement
|
Yes
|
* | Mr. Wirta is our current Board Chair. Our Board has appointed Mr. Boze to succeed Mr. Wirta as the Independent Chair of our Board, effective following the Annual Meeting, assuming Mr. Boze is re-elected at such meeting by our stockholders. |
(4) | The application of this term-limit restriction does not go into effect until December 17, 2020 for any of the companys directors who were serving on the Board as of December 17, 2015. See Corporate GovernanceTerm Limits on page 17. |
CBRE - 2018 Proxy Statement | 3 |
PROXY SUMMARY INFORMATION
Summary of Board Nominees
The following table provides summary information about each of the director nominees who is being voted on by stockholders at the Annual Meeting.
Name
|
Age
|
Director Since
|
Principal Occupation
|
Committees
|
Other Public Company Boards
|
|||||||||||
Brandon B. Boze*
|
|
37
|
|
|
2012
|
|
Partner of Value Act Capital
|
CC, GC
|
|
0
|
| |||||
Beth F. Cobert*
|
|
59
|
|
|
2017
|
|
Chief Executive Officer of Skillful
|
CC, GC
|
|
0
|
| |||||
Curtis F. Feeny*
|
|
60
|
|
|
2006
|
|
Managing Director of Silicon Valley Data Capital
|
AC, GC, EC
|
|
0
|
| |||||
Christopher T. Jenny*
|
|
62
|
|
|
2016
|
|
Senior Advisor to Parthenon-EY
|
AC, GC
|
|
0
|
| |||||
Gerardo I. Lopez*
|
|
58
|
|
|
2015
|
|
Former President and Chief Executive Officer of Extended Stay America, Inc.
|
CC, GC
|
|
1
|
| |||||
Paula R. Reynolds*
|
|
61
|
|
|
2016
|
|
President and Chief Executive Officer of PreferWest, LLC
|
AC, CC
|
|
3
|
| |||||
Robert E. Sulentic
|
|
61
|
|
|
2012
|
|
President and Chief Executive Officer of CBRE
|
EC
|
|
0
|
| |||||
Laura D. Tyson*
|
|
70
|
|
|
2010
|
|
Distinguished Professor of the Graduate School, Haas School of Business, University of California, Berkeley
|
AC
|
|
1
|
| |||||
Ray Wirta*
|
|
74
|
|
|
2001
|
|
Chief Executive Officer of The Koll Company and President of the Irvine Company
|
EC
|
|
0
|
| |||||
Sanjiv Yajnik*
|
|
61
|
|
|
2017
|
|
President of Capital One Financial Services
|
AC, CC
|
|
0
|
|
* | Independent Director |
| Mr. Wirta is our current Board Chair. Our Board has appointed Mr. Boze to succeed Mr. Wirta as the Independent Chair of our Board, effective following the Annual Meeting, assuming Mr. Boze is re-elected at such meeting by our stockholders. |
Key: | |
AC | Audit and Finance Committee |
CC | Compensation Committee |
EC | Executive Committee |
GC | Corporate Governance and Nominating Committee |
Executive Compensation Highlights
4 | CBRE - 2018 Proxy Statement |
PROXY SUMMARY INFORMATION
The total target direct compensation mix for 2017 for (i) our Chief Executive Officer (CEO) and (ii) our CEO together with our other named executive officers (NEOs) is illustrated in the following charts(5):
Annual CompensationSet forth below is the 2017 compensation for our named executive officers. See the footnotes accompanying the Summary Compensation Table on page 55 for more information.
Name and Principal Position
|
Year
|
Salary ($)
|
Bonus ($)
|
Annual Stock Awards ($)
|
Non-Equity Incentive Plan Compensation ($)
|
All Other Compensation ($)
|
Total ($)
|
|||||||||||||||||||||
Robert E. Sulentic President and Chief Executive Officer
|
|
2017
|
|
|
990,000
|
|
|
|
|
|
5,129,964
|
|
|
2,485,824
|
|
|
4,500
|
|
|
8,610,288
|
| |||||||
James R. Groch Chief Financial Officer and Global Director of Corporate Development
|
|
2017
|
|
|
770,000
|
|
|
150,000
|
|
|
2,999,938
|
|
|
1,436,512
|
|
|
4,500
|
|
|
5,360,950
|
| |||||||
Michael J. Lafitte Global Group President
|
|
2017
|
|
|
700,000
|
|
|
150,000
|
|
|
2,319,936
|
|
|
1,330,560
|
|
|
4,500
|
|
|
4,504,996
|
| |||||||
Calvin W. Frese, Jr. Global Group President
|
|
2017
|
|
|
695,000
|
|
|
|
|
|
2,319,936
|
|
|
1,305,920
|
|
|
4,500
|
|
|
4,325,356
|
| |||||||
William F. Concannon Global Group President and Chief Executive OfficerGlobal Workplace Solutions
|
|
2017
|
|
|
693,750
|
|
|
150,000
|
|
|
2,169,990
|
|
|
1,265,400
|
|
|
4,500
|
|
|
4,283,640
|
|
(5) | Excludes one-time Strategic Equity Awards granted to our named executive officers (other than Mr. Sulentic) in 2017. See One-Time Strategic Equity Award on page 5 above. |
CBRE - 2018 Proxy Statement | 5 |
CEO TARGET COMPENSATION MIX CEO + NEOS TARGET COMPENSATION MIX
PROXY SUMMARY INFORMATION
6 | CBRE - 2018 Proxy Statement |
CBRE - 2018 Proxy Statement | 7 |
Our Board has nominated 10 directors for election at this Annual Meeting to hold office until the next annual meeting and the election of their successors. All of the nominees currently are directors and were selected to serve on our Board based on:
Director Nomination Criteria: Qualifications, Skills and Experience
1 Theapplication of this term-limit restriction does not go into effect until December 17, 2020 for any of the companys directors who were serving on the Board as of December 17, 2015. See Term Limits on page 17.
8 | CBRE - 2018 Proxy Statement |
PROPOSAL 1
Director Skills Matrix
CBRE - 2018 Proxy Statement | 9 |
BUSINESS OPERATIONS DIVERSITY FINANCE GLOBAL BUSINESS LEADERSHIP M&A OTHER PUBLIC COMPANY BOARD SERVICE AND GOVERNANCE TECHNOLOGY
PROPOSAL 1
2018 Director Nominees
10 | CBRE - 2018 Proxy Statement |
PROPOSAL 1
CBRE - 2018 Proxy Statement | 11 |
PROPOSAL 1
12 | CBRE - 2018 Proxy Statement |
PROPOSAL 1
Messrs. Freeman and Malek, who currently serve on our Board, have a combined 32 years of director service to us. They will not stand for re-election and will retire from our Board at the expiration of their current terms at the Annual Meeting. We are grateful for their many years of service to CBRE.
CBRE - 2018 Proxy Statement | 13 |
PROPOSAL 1
The following summarizes the independence, diversity and tenure of our 2018 director nominees:
Required Vote
This is an uncontested Board election. As such, in order to be elected, each nominee must receive the affirmative vote of a majority of the votes cast on his or her election (i.e., votes cast FOR a nominee must exceed votes cast as AGAINST). Votes to ABSTAIN with respect to a nominee and broker non-votes are not considered votes cast, and so will not affect the outcome of the nominees election.
Recommendation
Our Board recommends that stockholders vote FOR all of the nominees.
14 | CBRE - 2018 Proxy Statement |
INDEPENDENCE DIVERSITY TENURE
GOVERNANCE HIGHLIGHTS
Corporate Governance | Compensation | Stockholder Rights | ||
10 director nominees, 9 of whom are independent |
Pay-for-performance compensation program, which includes performance-based equity grants
|
Annual election of all directors | ||
Director Term Limits (12 years)2 |
Annual say on pay votes, with most
|
Majority voting requirement for directors in uncontested elections | ||
Independent Chair of the Board |
Stock ownership requirements for directors and executive officers
|
Stockholder rights to call special meetings | ||
Regular executive sessions of independent directors
|
Policy restricting trading, and prohibiting hedging and short-selling, of CBRE stock
|
No poison pill takeover defense plans | ||
Risk oversight by the Board and its key committees
|
Compensation clawback policy for executive officers
|
Stockholders may act by written consent | ||
Maximum of one Board-nominated management director |
Proxy access for director nominations | |||
All incumbent directors attended at least 80% of Board and Board committee meetings
|
Ongoing stockholder outreach and engagement | |||
Robust Standards of Business Conduct and governance policies
|
||||
No over-boarding by our directors on other public-company boards
|
Process for Selecting Director Candidates
2 The application of this term-limit restriction does not go into effect until December 17, 2020 for any of the companys directors who were serving on the Board as of December 17, 2015. See Term Limits on page 17.
CBRE - 2018 Proxy Statement | 15 |
CORPORATE GOVERNANCE
Stockholder Recommendations and Nominations of Director Candidates
Director Independence
Independent Director Meetings
16 | CBRE - 2018 Proxy Statement |
CORPORATE GOVERNANCE
Majority Voting to Elect Directors
Director Resignation Policy Upon Change of Employment
Term Limits
Board Structure and Leadership
CBRE - 2018 Proxy Statement | 17 |
CORPORATE GOVERNANCE
Board Risk Management
Oversight of Risk
The Board oversees risk management.
Board committees, which meet regularly and report back to the full Board, play significant roles in carrying out our Boards risk oversight function.
Company management is charged with managing risk through rigorous risk mitigation activities and strong internal controls.
Succession Planning
Board Meetings and Committees
18 | CBRE - 2018 Proxy Statement |
CORPORATE GOVERNANCE
The following table describes the current members of each of the committees of our Board, and the number of meetings held during fiscal year 2017:
Director | Board | Audit and Finance |
Compensation | Governance | Executive | |||||
Brandon B. Boze |
ü | ü | ü | |||||||
Beth F. Cobert |
ü | CHAIR | ü | |||||||
Curtis F. Feeny |
ü | CHAIR | ü | ü | ||||||
Bradford M. Freeman(1) |
ü | ü | ü | |||||||
Christopher T. Jenny |
ü | ü | CHAIR | |||||||
Gerardo I. Lopez |
ü | ü | ü | |||||||
Frederic V. Malek(1) |
ü | ü | ||||||||
Paula R. Reynolds |
ü | ü | ü | |||||||
Robert E. Sulentic |
ü | ü | ||||||||
Laura D. Tyson |
ü | ü | ||||||||
Ray Wirta |
CHAIR | CHAIR | ||||||||
Sanjiv Yajnik |
ü | ü | ü | |||||||
Number of Meetings |
4 | 9 | 3 | 5 | 1 |
(1) | Messrs. Freeman and Malek currently serve on our Board, but will not stand for re-election and will retire from our Board following the expiration of their current terms at the Annual Meeting. |
CBRE - 2018 Proxy Statement | 19 |
CORPORATE GOVERNANCE
Board Attendance at Annual Meeting of Stockholders
Although the Board understands that there may be situations that prevent a director from attending an annual meeting of stockholders, it is the Boards policy that all directors should attend these meetings. All of our then-serving directors attended our 2017 annual meeting of stockholders on May 19, 2017.
Compensation Committee Interlocks and Insider Participation
The members of the Compensation Committee are set forth in the table on page 19. None of Messrs. Boze, Freeman, Lopez, Malek, Yajnik or Ms. Cobert and Reynolds has ever been an officer or employee of the company or any of its subsidiaries. In addition, during 2017, none of our directors was employed as an executive officer of another entity where any of our executive officers served on that entitys board of directors or compensation committee (or its equivalent).
Director Compensation
20 | CBRE - 2018 Proxy Statement |
CORPORATE GOVERNANCE
The following table provides information regarding compensation earned during the fiscal year ended December 31, 2017 by each non-employee director for his or her Board and committee service. Robert E. Sulentic, who is our President and CEO, is not compensated for his role as a director. Compensation information for Mr. Sulentic is described under Compensation Discussion and Analysis beginning on page 31 and under Executive Compensation beginning on page 54. For stock awards in the table below, the dollar amounts indicated reflect the aggregate grant date fair value for awards granted during the fiscal year ended December 31, 2017.
Name |
Fees Earned or Paid in Cash(1) ($) |
Stock Awards(2)(3) ($) |
Change in Pension Value and Nonqualified Deferred Compensation Earnings ($) |
Total ($) |
||||||||||||
Brandon B. Boze
|
|
83,000
|
|
|
149,977
|
|
|
|
|
|
232,977
|
| ||||
Beth F. Cobert
|
|
76,000
|
|
|
149,977
|
|
|
|
|
|
225,977
|
| ||||
Curtis F. Feeny
|
|
104,000
|
|
|
149,977
|
|
|
|
|
|
253,977
|
| ||||
Bradford M. Freeman(4)
|
|
81,000
|
|
|
149,977
|
|
|
3,692
|
|
|
234,669
|
| ||||
Christopher T. Jenny
|
|
98,000
|
|
|
149,977
|
|
|
|
|
|
247,977
|
| ||||
Gerardo I. Lopez(4)
|
|
82,000
|
|
|
149,977
|
|
|
342
|
|
|
232,319
|
| ||||
Frederic V. Malek(4)
|
|
88,000
|
|
|
149,977
|
|
|
3,090
|
|
|
241,067
|
| ||||
Paula R. Reynolds
|
|
87,000
|
|
|
149,977
|
|
|
|
|
|
236,977
|
| ||||
Laura D. Tyson
|
|
84,000
|
|
|
149,977
|
|
|
|
|
|
233,977
|
| ||||
Ray Wirta
|
|
76,000
|
|
|
149,977
|
|
|
|
|
|
225,977
|
| ||||
Sanjiv Yajnik(5)
|
|
38,115
|
|
|
76,219
|
|
|
|
|
|
114,334
|
|
(1) | Includes fees associated with the annual Board service retainer, attendance at committee meetings and chairing a Board committee. Our non-employee directors may elect to receive shares of our common stock in lieu of cash payments (in like amounts). We reflect these stock in lieu of cash payments under the column titled Fees Earned or Paid in Cash, and not under the Stock Awards column. |
(2) | This represents the grant date fair value under Financial Accounting Standards Board, Accounting Standards Codification (ASC), Topic 718, Stock Compensation, of all restricted stock units granted to the directors during 2017. See also Note 2 Significant Accounting Policies and Note 13 Employee Benefit Plans to our consolidated financial statements as reported in our Annual Report on Form 10-K for the fiscal year ended December 31, 2017 for a discussion of the valuation of our stock awards. |
(3) | Each of Ms. Cobert, Reynolds and Dr. Tyson and Messrs. Boze, Feeny, Freeman, Jenny, Lopez, Malek and Wirta was awarded 4,453 restricted stock units pursuant to our director compensation policy, valued at the fair market value of our common stock of $33.68 per share on the award date of May 19, 2017. |
(4) | Pursuant to our Deferred Compensation Plan, our non-employee directors are eligible to defer their director fees as described under Summary of Plans, Programs and AgreementsDeferred Compensation Plan on page 62. During 2017, the total deferred account balances (which included amounts deferred during 2017 as well as amounts deferred from prior years) for Messrs. Freeman, Lopez and Malek accrued interest at an annualized rate of 3.81% for the period from January 1, 2017 through March 31, 2017, 3.96% for the period from April 1, 2017 through June 30, 2017, 3.80% for the period from July 1, 2017 through September 30, 2017 and 3.65% for the period from October 1, 2017 through December 31, 2017. |
Mr. Freeman deferred a total of $81,000 of his 2017 cash compensation. Mr. Freemans total accrued interest for 2017 was $18,677.
Mr. Lopez deferred a total of $37,500 of his 2017 cash compensation. Mr. Lopezs total accrued interest for 2017 was $1,795.
Mr. Malek deferred a total of $88,000 of his 2017 cash compensation. Mr. Maleks total accrued interest for 2017 was $15,680.
In accordance with SEC rules regarding above-market interest on non-qualified deferred compensation, accrued interest for 2017 of $3,692, $342 and $3,090 for Messrs. Freeman, Lopez and Malek, respectively, is considered to be compensation and is shown in the Change in Pension Value and Nonqualified Deferred Compensation Earnings column based on a comparison to 120% of the long-term quarterly applicable federal rate for the months when the interest rate was set. |
(5) | Mr. Yajnik was appointed to our Board on November 14, 2017 and as such received pro-rated director compensation for 2017. The pro-rated portion of his annual cash retainer under our director compensation policy was $38,115 and the pro-rated portion of his equity grant was 1,807 restricted stock units, valued at the fair market value of our common stock of $42.18 per share on the award date of November 14, 2017. |
CBRE - 2018 Proxy Statement | 21 |
CORPORATE GOVERNANCE
The table below shows the aggregate number of stock awards (i.e., restricted stock units) and option awards outstanding for each non-employee director as of December 31, 2017:
Name
|
Aggregate Number of
|
Aggregate Number of Shares
|
||||||
Brandon B. Boze
|
|
4,453
|
|
|
|
| ||
Beth F. Cobert
|
|
4,453
|
|
|
|
| ||
Curtis F. Feeny
|
|
4,453
|
|
|
|
| ||
Bradford M. Freeman
|
|
4,453
|
|
|
1,886
|
| ||
Christopher T. Jenny
|
|
4,453
|
|
|
|
| ||
Gerardo I. Lopez
|
|
4,453
|
|
|
|
| ||
Frederic V. Malek
|
|
4,453
|
|
|
|
| ||
Paula R. Reynolds
|
|
4,453
|
|
|
|
| ||
Laura D. Tyson
|
|
4,453
|
|
|
1,886
|
| ||
Ray Wirta
|
|
4,453
|
|
|
1,886
|
| ||
Sanjiv Yajnik |
|
1,807 |
|
|
|
|
Corporate Governance Guidelines and Code of Ethics
22 | CBRE - 2018 Proxy Statement |
CORPORATE GOVERNANCE
Current copies of our Boards Standards of Business Conduct, Code of Ethics for Senior Financial Officers, Corporate Governance Guidelines, Policy Regarding Transactions with Interested Parties and Corporate Opportunities, Whistleblower Policy and Equity Award Policy are available on our website and in print upon written request to our Investor Relations Department at CBRE Group, Inc., 200 Park Avenue, New York, New York 10166, or by email at investorrelations@cbre.com. If the Board grants any waivers from the Boards Standards of Business Conduct or the Code of Ethics for Senior Financial Officers to any of our directors or executive officers, or if we amend such policies, we will, if required, disclose these matters through the Investor Relations section of our website on a timely basis.
Stock Ownership Requirements
Corporate Responsibility
CBRE - 2018 Proxy Statement | 23 |
CORPORATE GOVERNANCE
Stockholder Engagement
24 | CBRE - 2018 Proxy Statement |
CORPORATE GOVERNANCE
Communications with our Board
Submission of Stockholder Proposals and Board Nominees
CBRE - 2018 Proxy Statement | 25 |
CORPORATE GOVERNANCE
26 | CBRE - 2018 Proxy Statement |
PROPOSAL 2 RATIFY APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
Required Vote
Approval of this Proposal 2 requires the affirmative vote (i.e., FOR votes) of a majority of the shares present or represented and entitled to vote thereon at our 2018 Annual Meeting. A vote to ABSTAIN will count as present for purposes of this proposal and so will have the same effect as a vote AGAINST this proposal. In the absence of instructions, your broker may vote your shares on this proposal. For more information, see General Information about the Annual MeetingVoting Instructions and InformationIf you do not vote/effect of broker non-votes on page 82.
Recommendation
Our Board recommends that stockholders vote FOR ratification of the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2018.
CBRE - 2018 Proxy Statement | 27 |
The following table shows the fees for audit and other services provided by KPMG LLP for the fiscal years ended December 31, 2017 and 2016 (in millions):
Fees | Fiscal 2017 | Fiscal 2016 | ||||||
Audit Fees
|
$
|
10.7
|
|
|
9.6
|
| ||
Audit-Related Fees
|
|
2.5
|
|
|
2.5
|
| ||
Tax Fees(1)
|
|
1.1
|
|
|
4.7
|
| ||
All Other Fees
|
|
|
|
|
|
| ||
|
|
|
|
|||||
Total Fees
|
$
|
14.3
|
|
|
16.8
|
| ||
|
|
|
|
(1) | The year over year reduction in tax fees of $3.6 million is due to in-sourcing of tax compliance and tax planning work and the use of other third-party consultants. |
A description of the types of services provided in each category is as follows:
Audit and Finance Committee Pre-Approval Process
Audit and Finance Committee Report
28 | CBRE - 2018 Proxy Statement |
AUDIT AND OTHER FEES
CBRE - 2018 Proxy Statement | 29 |
PROPOSAL 3 ADVISORY VOTE ON EXECUTIVE COMPENSATION
Required Vote
Approval of this Proposal 3 requires the affirmative vote (i.e., FOR votes) of a majority of the shares present or represented and entitled to vote thereon at our 2018 Annual Meeting. A vote to ABSTAIN will count as present for purposes of this proposal and so will have the same effect as a vote AGAINST this proposal. A broker non-vote will not count as present, and so will have no effect in determining the outcome with respect to this proposal.
Recommendation
Our Board recommends that stockholders vote FOR the advisory approval of the compensation of our named executive officers for the fiscal year ended December 31, 2017.
30 | CBRE - 2018 Proxy Statement |
COMPENSATION DISCUSSION AND ANALYSIS
This Compensation Discussion and Analysis, or CD&A, provides you with detailed information regarding the material elements of compensation paid to our executive officers, including the considerations and objectives underlying our compensation policies and practices. Although our executive compensation program is generally applicable to all of our executive officers, this CD&A focuses primarily on the program as applied to the following executives (whom we refer to as named executive officers):
Robert E. Sulentic
|
President and CEO
|
|||
James R. Groch
|
Chief Financial Officer and Global Director of Corporate Development
|
|||
Michael J. Lafitte
|
Global Group President
|
|||
Calvin W. Frese, Jr.
|
Global Group President
|
|||
William F. Concannon
|
Global Group President and Chief Executive OfficerGlobal Workplace Solutions
|
2017 Executive Summary
Business Highlights
In fiscal year 2017, we delivered strong results. Some highlights are as follows:
| Our revenue totaled $14.2 billion, up 9% from 2016. |
| Our fee revenue totaled $9.4 billion, up 8% from 2016.3,4 |
| On a GAAP basis, net income for 2017 increased 21% to $691.5 million and earnings per diluted share rose 20% to $2.03 per share. |
| Our adjusted net income was $924.5 million, up 19% from 2016. 4 |
| Our adjusted EPS was $2.71, up 18% from 2016. 4 |
| Our adjusted EBITDA was $1.7 billion, up 10% from 2016. 4 |
| Our revenue mix has shifted in recent years toward more contractual revenue as occupiers and investors increasingly prefer to purchase integrated, account-based services from firms that meet the full spectrum of their needs nationally and globally. |
| We generated revenue from a highly-diversified base of clients. In 2017, our client roster included over 90 of the Fortune 100 companies. |
| We executed a highly targeted M&A strategy, closing 11 acquisitions in 2017 that enhanced our capabilities, including companies operating in investment management, project management, retail experience advisory services, occupier brokerage focused on major technology companies, as well as two real estate software as a service companies. |
| We added significantly to our talent base, with one of our best years for producer recruiting, and strengthened the leadership team that is responsible for driving our continued growth. |
| We have been voted the most recognized commercial real estate brand in a Lipsey Company survey for 17 years in a row (including 2018) and we have been rated a Worlds Most Ethical Company by the Ethisphere Institute for five consecutive years (including 2018). |
| We ended 2017 in a very strong financial position with low leverage, high liquidity and considerable cash flow. |
3 Fee revenue is gross revenue less both client reimbursed costs largely associated with employees that are dedicated to client facilities and subcontracted vendor work performed for clients.
4 For supplemental financial data and a corresponding reconciliation of (i) revenue computed in accordance with GAAP to fee revenue (ii) net income computed in accordance with GAAP to adjusted EBITDA and (iii) net income computed in accordance with GAAP to adjusted net income and to adjusted EPS, in each case for the fiscal years ended December 31, 2017 and 2016, please see Annex A to this Proxy Statement.
CBRE - 2018 Proxy Statement | 31 |
COMPENSATION DISCUSSION AND ANALYSIS
The following charts highlight our growth in adjusted EBITDA, adjusted net income and adjusted EPS for 2017 relative to 2016:
Executive Compensation Highlights
32 | CBRE - 2018 Proxy Statement |
ADJUSTED EBITDA $ in millions ADJUSTED NET INCOME $ in millions ADJUSTED EPS
COMPENSATION DISCUSSION AND ANALYSIS
CBRE - 2018 Proxy Statement | 33 |
COMPENSATION DISCUSSION AND ANALYSIS
COMPONENTS OF OUR EXECUTIVE COMPENSATION PROGRAM
Compensation Component |
Description and Purpose | Committee Actions for 2017 | ||||||
Base Salary |
Provides a minimum level of fixed compensation necessary to attract and retain senior executives. Set at a level that recognizes the skills, experience, leadership and individual contribution of each executive as well as the scope and complexity of the executives role, including due consideration given to appropriate comparator group benchmarking.
|
In 2017, the Committee increased base salaries for the following executives relative to 2016: Mr. Frese to $700,000 (an increase of $20,000). Mr. Concannon to $700,000 (an increase of $25,000). The other named executive officers did not receive base salary increases for 2017 relative to 2016. |
||||||
Annual Performance Awards |
Variable cash incentive opportunity tied to achievement of financial and individual strategic objectives. The financial performance measure used to determine a significant portion of each executives earned award is adjusted EBITDA as measured at the global level and, for Mr. Concannon, also as measured at the GWS business level. We believe that adjusted EBITDA is the best measure to evaluate our operating performance because it excludes certain items that management does not consider directly indicative of the companys ongoing performance. Each executive had a target cash performance award opportunity, 80% of which (the financial portion) was impacted by the companys financial performance and 20% of which (the strategic measures portion) was impacted by both the companys financial performance and the executives personal performance against strategic performance objectives. An executive may also earn a supplemental and discretionary bonus award in cases of exceptional and exceedingly deserving circumstances. |
In 2017, the Committee increased the target annual performance award for the following executives relative to 2016: Mr. Sulentic to $1,980,000 (an increase of $495,000). Mr. Frese to $1,050,000 (an increase of $30,000). Mr. Concannon to $1,000,000 (an increase of $25,000). 2017 target annual performance award opportunities for the other named executive officers were unchanged from 2016. Global Adjusted EBITDA for 2017 was $1.7 billion, which was above the target level and resulted in a financial adjustment factor of 117.3%. Adjusted EBITDA for our Global Workplace Solutions business line was $517.3 million, which was also above target, and resulted in a financial adjustment factor of 117.0%. The financial adjustment factor for Messrs. Sulentic, Groch, Lafitte and Frese was based solely on Global Adjusted EBITDA, whereas Global Adjusted EBITDA comprised half of the financial adjustment factor for Mr. Concannon and Adjusted EBITDA for our Global Workplace Solutions business line determined the other half. Each named executive officer exceeded their strategic performance objectives, resulting in strategic adjustment factors ranging from 130% to 140%. In addition, the CEO recommended, and the Committee approved supplemental bonus awards for Messrs. Groch, Lafitte, and Concannon for their exemplary leadership and outstanding performance in growing the company during 2017. For more detail on each named executive officers target bonus opportunity and the performance factors considered in determining actual earned bonuses for 2017, please refer to the discussion beginning on page 41 in this CD&A.
|
||||||
Annual Long-Term Incentives |
Annual grants of restricted stock units intended to align the interests of our executives with those of stockholders over a multi-year period, and to support executive retention objectives. Generally, our executives will receive two-thirds of their target annual long-term incentive award value in the form of a Time Vesting Equity Award, and one-third of their target award value in the form of an Adjusted EPS Equity Award. (We describe these two types of awards in greater detail under the heading Components of Our ProgramElements of our compensation program beginning on page 47). |
In 2017, the Committee increased the annual long-term equity target for the following executives relative to 2016: Mr. Sulentic to $5,630,000 (an increase of $1,505,000). After his 2017 target long-term equity incentive award had been established by our Board of Directors, Mr. Sulentic requested, and our Board agreed, to reduce his 2017 target long-term equity incentive award by $500,000. Therefore, Mr. Sulentics actual long-term equity incentive target for 2017 was $5,130,000 (an increase of $1,005,000). Mr. Frese to $2,320,000 (an increase of $70,000). Mr. Concannon to $2,170,000 (an increase of $120,000). 2017 annual long-term equity targets for the other named executive officers were unchanged from 2016. In 2016, the Committee changed our annual equity grant date from August to March, effective March 2017. To effectuate this change in annual grant timing, in August 2016, the Committee awarded our executives a stub grant, as a bridge between August 2016 and the date of the next annual grant in March 2017. The stub grant value was equal to 50% of each named executive officers target annual
|
34 | CBRE - 2018 Proxy Statement |
COMPENSATION DISCUSSION AND ANALYSIS
Compensation Component |
Description and Purpose | Committee Actions for 2017 | ||||||
long-term incentive award value and consisted solely of a Time Vesting Equity Award. As such, our executives received 100% of their target annual equity award target annual equity award in August 2015, 50% of their target annual equity award in August 2016 and 100% target annual equity award in March 2017. As a consequence, aggregate executive compensation was lower in 2016 as compared to 2015 and 2017. The March 2017 annual equity awards granted to Messrs. Groch, Lafitte, Frese and Concannon were granted at the normal target grant value, 50% in the form of a Time Vesting Equity Award and 50% in the form of an Adjusted EPS Equity Award to maintain the two-thirds time-based, one-third performance-based mix for the combined August 2016 and March 2017 awards. As noted above, Mr. Sulentic was also awarded an annual equity award in March 2017 in the amount of $5,630,000, which Mr. Sulentic requested, and our Board agreed, to reduce by $500,000. Therefore, Mr. Sulentics actual long-term equity incentive target for 2017 was $5,130,000, an increase of $1,005,000 over the prior year. Two-thirds of the incremental increase to Mr. Sulentics annual equity award was granted in the form of an Adjusted EPS Equity Award and one-third was granted in the form of a Time Vesting Equity Award. With respect to the remaining $4,125,000 portion of his annual equity award, 50% was granted in the form of a Time Vesting Equity Award and the other 50% was granted in the form of an Adjusted EPS Equity Award. The Adjusted EPS Equity Awards granted in 2015 were earned at 169.2% of target, based on our cumulative Adjusted EPS of $5.01 for 2016 and 2017.
|
||||||||
One-Time Strategic |
One-time strategic equity award with a six-year vesting period intended to provide our executives with a significant and incremental financial incentive that aligns with the outcomes that we generate for our stockholders. |
In 2017, in exchange for the execution of certain restrictive covenants described below, the Committee made a one-time Strategic Equity Award with a six-year cliff vesting performance period to a group of our most senior executives around the globe, including each of our named executive officers (other than Mr. Sulentic who declined the award as described below). Our named executive officers (other than Mr. Sulentic) each received awards with a target grant date value of $5,500,000 (two-thirds of which is performance-based). The Committee also offered Mr. Sulentic a significant Strategic Equity Award. Mr. Sulentic determined (and the Committee agreed) that it was in the best interest of the company that Mr. Sulentic decline such award in order to maintain his independence and avoid any conflict of interest or appearance of conflict of interest as he was actively involved in designing the program and advocating for such awards and the related restrictive covenants with both our Board and our senior executives around the globe. As a condition to receiving the Strategic Equity Award, the group of global senior executives participating in the program, including Messrs. Groch, Lafitte, Frese and Concannon entered into a restrictive covenants agreement with the company which provides for certain post-termination non-competition, non-solicitation of clients and non-solicitation of employees covenants. Although Mr. Sulentic declined his Strategic Equity Award as stated above, he nonetheless entered into the same restrictive covenants agreement with the company as our other named executive officers. All of our senior executives who were offered such Strategic Equity Award accepted their awards and executed the required restrictive covenants agreement.
|
CBRE - 2018 Proxy Statement | 35 |
COMPENSATION DISCUSSION AND ANALYSIS
Compensation Component |
Description and Purpose | Committee Actions for 2017 | ||||||
The Strategic Equity Award differs from our annual equity awards in several ways: The Strategic Equity Award is earned over a six-year cliff vesting performance period, which is much longer than typical market practice for ongoing annual equity awards. The payout on two-thirds of the Strategic Equity Award is performance-based and is driven by the extent to which the company achieves rigorous cumulative Adjusted EPS and total shareholder return performance hurdles relative to the S&P 500 over a six-year performance period. For each measure, none of the performance-based awards will be earned unless our performance is above the 50th percentile. The remaining one-third of the Strategic Equity Award cliff vests based on continued service for a six-year vesting period. For more detail on the design of the Strategic Equity Award, please refer to the discussion beginning on page 47 in this CD&A.
|
Corporate Governance Highlights
Compensation and Corporate Governance Policies and Practices | ||||
Independence |
We have a Compensation Committee that is 100% independent. The Committee engages its own compensation consultant and confirms each year that the consultant has no conflicts of interest and is independent.
|
|||
No Hedging |
We have a policy prohibiting all directors and employees from engaging in any hedging transactions with CBRE securities held by them, which includes the purchase of any financial instrument (including prepaid variable forward contracts, equity swaps and collars) designed to hedge or offset any decrease in the market value of our securities.
|
|||
Compensation |
We have a compensation clawback policy that permits the company, subject to the discretion and approval of our Board, to recover cash-based and performance-based-equity incentive compensation paid to any current or former Section 16 officer if there is a restatement of our financial results in certain circumstances. These circumstances are described in greater detail in this CD&A under the heading Other Relevant Policies and PracticesCompensation Clawback Policy on page 50.
|
|||
Stock Ownership Requirements |
We have stock ownership requirements for directors
and our executive officers that require retention of threshold amounts of the net shares acquired upon the exercise of stock options,
|
|||
Equity Award Policy |
We have an Equity Award Policy that is designed to maintain the integrity of the equity award process and to ensure compliance with all applicable laws. The Equity Award Policy sets forth the procedures that must be followed in connection with employee awards and imposes stringent controls around any award made outside of the normal cycle. Our Equity Award Policy is described in greater detail in this CD&A under the heading Other Relevant Policies and PracticesEquity Award Policy and procedures for equity grants on page 50.
|
|||
No Single Trigger Change of Control Payments |
We do not have employment contracts, plans or other agreements that provide for single trigger change of control payments or benefits (including automatic accelerated vesting of equity awards upon a change of control only) to any of our named executive officers.
|
|||
No Special Perquisites |
Our named executive officers receive no special perquisites or other personal benefits, unless such benefits serve a reasonable business purpose, such as benefits specifically relating to healthcare and insurance.
|
|||
No Tax Gross-Ups |
As a policy matter, we do not provide tax gross-ups to our named executive officers. |
36 | CBRE - 2018 Proxy Statement |
COMPENSATION DISCUSSION AND ANALYSIS
Philosophy and Objectives of Our Executive Compensation Program
How We Make Compensation Decisions
Our Compensation Committee
CBRE - 2018 Proxy Statement | 37 |
COMPENSATION DISCUSSION AND ANALYSIS
Our Chief Executive Officer
The Committees Independent Compensation Consultant
38 | CBRE - 2018 Proxy Statement |
COMPENSATION DISCUSSION AND ANALYSIS
Comparative Market Data
AECOM
|
Jones Lang LaSalle Incorporated |
|||||
Aon plc
|
ManpowerGroup Inc. |
|||||
Brookfield Asset Management Inc.
|
Marsh & McLennan Companies, Inc. |
|||||
Cognizant Technology Solutions Corporation
|
Realogy Holdings Corp |
|||||
Computer Sciences Corporation*
|
Xerox Corporation |
|||||
Fidelity National Financial, Inc.
|
Waste Management, Inc. |
|||||
Fluor Corporation
|
Willis Group Holdings Public Limited Company |
|||||
Jacobs Engineering Group Inc.
|
* | On April 3, 2017, Computer Sciences Corporation merged with the Enterprise Services business of HP Enterprise to create DXC Technology. DXC Technology was added to the comparator group for 2018 planning purposes. |
Say on Pay Results
CBRE - 2018 Proxy Statement | 39 |
COMPENSATION DISCUSSION AND ANALYSIS
Stockholder Outreach
Compensation Risk Assessment
Components of Our Program
Elements of our compensation program
5 Excludes one-time Strategic Equity Awards granted to our named executive officers (other than Mr. Sulentic) in 2017. Please refer to the discussion under One-Time Strategic Equity Award beginning on page 47 for additional information regarding these awards.
40 | CBRE - 2018 Proxy Statement |
CEO TARGET COMPENSATION MIX CEO + NEOS TARGET COMPENSATION MIX
COMPENSATION DISCUSSION AND ANALYSIS
Name | 2017 Base Salary |
Change from 2016 | ||||
Robert E. Sulentic President and Chief Executive Officer
|
$ |
990,000 |
|
No change. | ||
James R. Groch Chief Financial Officer and Global Director of Corporate Development
|
$ |
770,000 |
|
No change. | ||
Michael J. Lafitte Global Group President
|
$ |
700,000 |
|
No change. | ||
Calvin W. Frese, Jr. Global Group President
|
$ |
700,000 |
|
Increased in 2017 by $20,000. | ||
William F. Concannon Global Group President and Chief Executive OfficerGlobal Workplace Solutions
|
$ |
700,000 |
|
Increased in 2017 by $25,000. |
Name | 2017 EBP Target Awards |
Change from 2016 | ||||
Robert E. Sulentic President and Chief Executive Officer
|
$ |
1,980,000 |
|
Increased in 2017 by $495,000. | ||
James R. Groch Chief Financial Officer and Global Director of Corporate Development
|
$ |
1,155,000 |
|
No change. | ||
Michael J. Lafitte Global Group President
|
$ |
1,050,000 |
|
No change. | ||
Calvin W. Frese, Jr. Global Group President
|
$ |
1,050,000 |
|
Increased in 2017 by $30,000. | ||
William F. Concannon Global Group President and Chief Executive OfficerGlobal Workplace Solutions
|
$ |
1,000,000 |
|
Increased in 2017 by $25,000. |
CBRE - 2018 Proxy Statement | 41 |
COMPENSATION DISCUSSION AND ANALYSIS
The 2017 adjusted EBITDA targets for our named executive officers, as compared to actual adjusted EBITDA in 2017, were as follows:
Target for 2017 adjusted EBITDA |
Actual 2017 adjusted EBITDA |
Relevant Business Measure Weighting |
||||||||||
Robert E. Sulentic President and Chief Executive Officer James R. Groch Chief Financial Officer and Global Director of Corporate Development Michael J. Lafitte Global Group President Calvin W. Frese, Jr. Global Group President
|
$ | 1,625.6 million | $ | 1,709.5 million | Global (100%) | |||||||
William F. Concannon Global Group President and Chief Executive OfficerGlobal
|
$ $ |
492.2 million 1,625.6 million |
|
$ $ |
517.3 million 1,709.5 million |
7
|
|
Global Workplace Solutions (50%) Global (50%) |
|
6 For additional information on adjusted EBITDA, please see footnote (3) under Proxy Summary Information on page 2.
7 For a reconciliation of net income computed in accordance with GAAP to EBITDA and adjusted EBITDA for our Global Workplace Solutions business for the fiscal year ended December 31, 2017, see Annex A to this Proxy Statement.
42 | CBRE - 2018 Proxy Statement |
COMPENSATION DISCUSSION AND ANALYSIS
CBRE - 2018 Proxy Statement | 43 |
COMPENSATION DISCUSSION AND ANALYSIS
The table below generally describes the financial and strategic measures applied to each of our named executive officers and their resulting payouts against targets under the EBP for 2017.
Name | Financial Measures | Strategic Measures | 2017 Target | 2017 Payout | ||||||||
Robert E. Sulentic President and Chief Executive Officer |
Global adjusted EBITDA100% |
Mr. Sulentic was expected to achieve specific objectives set for him in the following general areas in support of the companys corporate strategy: Execute the initiatives identified in the companys business strategy refresh Advancement of leadership structure Data strategy advancements Execution of Global Investors strategic plan Upgrade corporate strategy function Support the companys diversity initiative |
|
$ 1,980,000 |
|
|
$ 2,485,824 |
| ||||
Actual Achievement Against Target: 105.2% Adjustment Factor: 117.3%
|
Strategic Performance Rating: 135% | |||||||||||
James R. Groch Chief Financial Officer and Global Director of Corporate Development |
Global adjusted EBITDA100% |
Mr. Groch was expected to achieve specific objectives set for him in the following general areas in support of the companys corporate strategy: Strategically invest the companys capital Strengthen the companys finance and corporate development capabilities Lead cost containment efforts Support the companys diversity initiative |
|
$ 1,155,000 |
|
|
$ 1,436,512(1) |
| ||||
Actual Achievement Against Target: 105.2% Adjustment Factor: 117.3%
|
Strategic Performance Rating: 130% | |||||||||||
Michael J. Lafitte Global Group President |
Global adjusted EBITDA100% |
Mr. Lafitte was expected to achieve specific objectives set for him in the following general areas in support of the companys corporate strategy: Advance the companys project management business Devise and implement a new Capital Markets strategy Implement digital and technology initiatives in the companys advisory and GWS business Advance the companys client care program Support cost containment efforts Support the companys diversity initiative |
|
$ 1,050,000 |
|
|
$ 1,330,560(1) |
| ||||
Actual Achievement Against Target: 105.2% Adjustment Factor: 117.3%
|
Strategic Performance Rating: 140% |
(1) | This amount does not include a supplemental and discretionary bonus award of $150,000 granted to each of Messrs. Groch and Lafitte under our EBP in recognition of their exemplary leadership and outstanding performance in growing the company during 2017. Including this supplemental bonus award, the total EBP award for Messrs. Groch and Lafitte for 2017 was $1,586,512 and $1,480,560, respectively. A further explanation of this supplemental bonus award is provided immediately below this table. |
44 | CBRE - 2018 Proxy Statement |
COMPENSATION DISCUSSION AND ANALYSIS
Name | Financial Measures | Strategic Measures | 2017 Target | 2017 Payout | ||||||||
Calvin W. Frese, Jr. Global Group President |
Global adjusted EBITDA100% |
Mr. Frese was expected to achieve specific objectives set for him in the following general areas in support of the companys corporate strategy: Develop and execute a plan to scale the companys private client capital markets business Senior executive development, succession planning and alignment of senior executive compensation in EMEA and Asia Pacific Advance collaboration between geographic/line of business leaders and corporate development in establishing M&A priorities Lead the companys bureaucracy reduction initiative Support cost containment efforts Support the companys diversity initiative
|
|
$ 1,050,000 |
|
|
$ 1,305,920 |
| ||||
Actual Achievement Against Target: 105.2%
Adjustment Factor: 117.3% |
Strategic Performance Rating: 130% | |||||||||||
William F. Concannon Global Group President and Chief Executive OfficerGlobal Workplace Solutions |
Global adjusted EBITDA50% Global Workplace Solutions adjusted EBITDA50% |
Mr. Concannon was expected to achieve specific objectives set for him in the following general areas in support of the companys corporate strategy: Advance the companys project management business and facilities management business Develop and implement a plan for local facilities management expansion Support the companys client care program Support the companys diversity initiative |
|
$ 1,000,000 |
|
|
$ 1,265,400(2) |
| ||||
Actual Achievement Against Target: 105.2% (Global); 105.1% (Global Workplace Solutions)
Global Adjustment Factor: 117.3% Global Workplace Solutions Adjustment Factor: 117.0%
|
Strategic Performance Rating: 140% |
(2) | This amount does not include a supplemental and discretionary bonus award of $150,000 granted to Mr. Concannon under our EBP in recognition of his exemplary leadership and outstanding performance during 2017. Including this supplemental bonus award, the total EBP award for Mr. Concannon for 2017 was $1,415,400. A further explanation of this supplemental bonus award is provided immediately below this table. |
CBRE - 2018 Proxy Statement | 45 |
COMPENSATION DISCUSSION AND ANALYSIS
Annual Long-Term Incentive Program
The table below represents the dollar values (measured at grant date fair value) underlying the annual equity awards that were made to our named executive officers for 2017.
Name | Adjusted EPS Equity Award (at Target)(1)(2)(4) |
Time Vesting Equity Award(1)(3)(4) |
Total 2017 Annual |
Change from 2016 Target | ||||
Robert E. Sulentic President and Chief Executive Officer
|
$ 2,732,500 |
$ 2,397,500 |
$ 5,130,000(5) |
Increased in 2017 by $1,005,000. | ||||
James R. Groch Chief Financial Officer and Global Director of Corporate Development
|
$ 1,500,000 |
$ 1,500,000 |
$ 3,000,000(4) |
No change.(6) | ||||
Michael J. Lafitte Global Group President
|
$ 1,160,000 |
$ 1,160,000 |
$ 2,320,000(4) |
No change.(6) | ||||
Calvin W. Frese, Jr. Global Group President
|
$ 1,160,000 |
$ 1,160,000 |
$ 2,320,000(4) |
Increased in 2017 by $70,000. | ||||
William F. Concannon(7) Global Group President and Chief Executive OfficerGlobal Workplace Solutions
|
$ 1,085,000 |
$ 1,085,000 |
$ 2,170,000(4) |
Increased in 2017 by $120,000. |
(1) | These amounts reflect the Committee-approved award values, with the actual number of restricted stock units granted rounded down to the nearest whole share as set forth on the Grants of Plan-Based Awards table on page 56. |
(2) | The Adjusted EPS Equity Award was granted with a target number of restricted stock units, zero to 200% of which may be earned based on our achievement against adjusted EPS performance targets (over a minimum threshold) as measured on a cumulative basis for the 2017 and 2018 fiscal years, with full vesting of any earned amount on March 3, 2020. If actual adjusted EPS is less than the minimum threshold, then none of the units will be earned. The maximum number of units available under the award is 200% of the target number of units, and there is linear interpolation between the various adjusted EPS performance targets. |
(3) | The Time Vesting Equity Award will vest 25% per year on each of March 3, 2018, 2019, 2020 and 2021. |
(4) | With respect to Messrs. Groch, Lafitte, Frese and Concannon, 50% of each of their 2017 annual equity award was granted in the form of an Adjusted EPS Equity Award and the other 50% was granted in the form of a Time Vesting Equity Award. |
(5) | In 2017, the Board set Mr. Sulentics long-term equity award at $5,630,000. After his 2017 long-term equity incentive award had been established by our Board, Mr. Sulentic requested, and our Board agreed, to reduce his award by $500,000. Therefore, Mr. Sulentics actual long-term equity incentive award for 2017 was $5,130,000, an increase of $1,005,000 over the prior year. Two-thirds of the incremental increase to Mr. Sulentics long-term equity award was granted in the form of an Adjusted EPS Equity Award and one-third was granted in the form of a Time Vesting Equity Award. With respect to the remaining $4,125,000 portion of his 2017 annual equity award, 50% was granted in the form of an Adjusted EPS Equity Award and the other 50% was granted in the form of a Time Vesting Equity Award. |
(6) | In 2016, our named executive officers received a stub grant equal to 50% of their normal target grant value as a result of the change in annual grant timing. |
(7) | Mr. Concannon became retirement-eligible in November 2017. For additional information regarding the treatment of his outstanding equity awards upon retirement, please refer to the discussion under Severance Plan; Treatment of Death, Disability and Retirement Under 2014, 2015, 2016 and 2017 Equity Award Agreements; Treatment of Qualifying Termination and Retirement Under Strategic Equity Award Agreements beginning on page 63. |
46 | CBRE - 2018 Proxy Statement |
COMPENSATION DISCUSSION AND ANALYSIS
CBRE - 2018 Proxy Statement | 47 |
COMPENSATION DISCUSSION AND ANALYSIS
The performance and payout schedule for the rTSR and rEPS Strategic Equity Awards is intended to be extremely challenging, as evidenced by the fact that such performance awards will not vest unless the companys performance on the relevant metric exceeds 50th percentile performance. The payout schedule for the rTSR and rEPS Strategic Equity Awards is as follows:
CBREs rTSR Performance (Percentile Rank) |
% of Target rTSR Share Units that Vest |
CBREs rEPS Performance (Percentile Rank) |
% of Target rEPS Share Units that Vest | |||
<= 50th Percentile
|
0%
|
<= 50th Percentile
|
0%
| |||
>= 75th Percentile
|
175%
|
>= 75th Percentile
|
175%
|
Additional Elements of Our Compensation Program
48 | CBRE - 2018 Proxy Statement |
COMPENSATION DISCUSSION AND ANALYSIS
Other Relevant Policies and Practices
Equity Ownership Policy
STOCK OWNERSHIP REQUIREMENT
Name
|
Minimum Requirement
|
|||
Robert E. Sulentic President and Chief Executive Officer
|
|
5x Base Salary
|
| |
James R. Groch Chief Financial Officer and Global Director of Corporate Development
|
|
3x Base Salary
|
| |
Michael J. Lafitte Global Group President
|
|
3x Base Salary
|
| |
Calvin W. Frese, Jr. Global Group President
|
|
3x Base Salary
|
| |
William F. Concanon Global Group President and Chief Executive OfficerGlobal Workplace Solutions
|
|
3x Base Salary
|
|
CBRE - 2018 Proxy Statement | 49 |
COMPENSATION DISCUSSION AND ANALYSIS
A further description of this policy and the applicable thresholds can be found under Corporate GovernanceStock Ownership Requirements on page 23.
Policies restricting stock trading and prohibiting hedging and short-selling
Compensation Clawback Policy
Equity Award Policy and procedures for equity grants
50 | CBRE - 2018 Proxy Statement |
COMPENSATION DISCUSSION AND ANALYSIS
Tax Deductibility and Accounting Implications
Compensation Committee Report
CBRE - 2018 Proxy Statement | 51 |
We have provided below summary biographies of our named executive officers who are described above in the CD&A, as well as our other executive officers as of March 20, 2018 (other than Mr. Sulentic). Information on Mr. Sulentic can be found on page 12 under Elect Directors2018 Director Nominees.
52 | CBRE - 2018 Proxy Statement |
EXECUTIVE MANAGEMENT
CBRE - 2018 Proxy Statement | 53 |
Summary Compensation Table
The following table sets forth compensation information in respect of the fiscal years ended December 31, 2017, 2016 and 2015 for our CEO, Chief Financial Officer and the three other most highly compensated executive officers for 2017.
Name and Principal Position |
Year | Salary ($) |
Bonus(1) ($) |
Annual Stock Award (2)(3)(4) ($) |
One-Time ($) |
Total Awards(6) ($) |
Non-Equity Incentive Plan Compensation(7) ($) |
All Other Compensation(8) ($) |
Total ($) |
|||||||||||||||||||||||||||
Robert E. Sulentic |
2017 | 990,000 | | 5,129,964 | (9)(10) | | 5,129,964 | (8)(9) | 2,485,824 | 4,500 | 8,610,288 | |||||||||||||||||||||||||
President and Chief Executive Officer |
2016 | 990,000 | 500,000 | 2,062,494 | | 2,062,494 | 1,403,800 | 4,500 | 4,960,794 | |||||||||||||||||||||||||||
2015 | 967,500 | 607,130 | 4,124,980 | | 4,124,980 | 1,992,870 | 3,750 | 7,696,230 | ||||||||||||||||||||||||||||
James R. Groch |
2017 | 770,000 | 150,000 | 2,999,938 | 5,637,461 | 8,637,399 | 1,436,512 | 4,500 | 10,998,411 | |||||||||||||||||||||||||||
Chief Financial
Officer and Global Director of Corporate Development |
2016 | 770,000 | 300,000 | 1,499,982 | | 1,499,982 | 1,081,700 | 4,500 | 3,656,182 | |||||||||||||||||||||||||||
2015 | 752,500 | 500,000 | 2,999,930 | | 2,999,930 | 1,550,000 | 3,750 | 5,806,180 | ||||||||||||||||||||||||||||
Michael J. Lafitte |
2017 | 700,000 | 150,000 | 2,319,936 | 5,637,461 | 7,957,397 | 1,330,560 | 4,500 | 10,142,457 | |||||||||||||||||||||||||||
Global Group President |
2016 | 700,000 | 350,000 | 1,159,972 | | 1,159,972 | 992,600 | 4,500 | 3,207,072 | |||||||||||||||||||||||||||
2015 | 675,000 | 400,000 | 2,319,980 | | 2,319,980 | 1,409,100 | 3,750 | 4,807,830 | ||||||||||||||||||||||||||||
Calvin W. Frese, Jr. |
2017 | 695,000 | | 2,319,936 | 5,637,461 | 7,957,397 | 1,305,920 | 4,500 | 9,962,817 | |||||||||||||||||||||||||||
Global Group President |
2016 | 680,000 | 300,000 | 1,124,994 | | 1,124,994 | 957,700 | 4,500 | 3,067,194 | |||||||||||||||||||||||||||
2015 | 660,000 | 400,000 | 2,249,948 | | 2,249,948 | 1,282,800 | 3,750 | 4,596,498 | ||||||||||||||||||||||||||||
William F. Concannon(11) Global Group President and CEOGlobal Workplace Solutions |
2017 | 693,750 | 150,000 | 2,169,990 | 5,637,461 | 7,807,451 | 1,265,400 | 4,500 | 9,921,101 | |||||||||||||||||||||||||||
2016 | 675,000 | 300,000 | 1,024,989 | | 1,024,989 | 848,900 | 4,500 | 2,853,389 | ||||||||||||||||||||||||||||
2015 | 650,000 | 300,000 | 2,049,924 | | 2,049,924 | 1,180,900 | 3,750 | 4,184,574 | ||||||||||||||||||||||||||||
54 | CBRE - 2018 Proxy Statement |
EXECUTIVE COMPENSATION
(1) | For 2017, Messrs. Groch, Lafitte and Concannon each received a $150,000 supplemental and discretionary bonus award granted under our EBP, in recognition of their exemplary leadership and outstanding performance in growing the company during 2017. |
(2) | See Note 2 (Significant Accounting Policies) and Note 13 (Employee Benefit Plans) to our consolidated financial statements as reported in our Annual Report on Form 10-K for the fiscal year ended December 31, 2017 for a discussion of the valuation of our stock awards. |
(3) | Our 2017 annual equity awards were made under and governed by the 2012 Equity Incentive Plan, as described under Summary of Plans, Programs and Agreements on page 60, and include (i) Time Vesting Equity Awards that were granted to each of Messrs. Sulentic, Groch, Lafitte, Frese and Concannon in the amount of 65,811, 41,174, 31,841, 31,841 and 29,783 restricted stock units, respectively, which are scheduled to vest 25% per year over four years (on each of March 3, 2018, 2019, 2020 and 2021) and (ii) Adjusted EPS Equity Awards that were granted to each of Messrs. Sulentic, Groch, Lafitte, Frese and Concannon with a target unit amount equal to 75,006, 41,174, 31,841, 31,841 and 29,783 restricted stock units, respectively, which are eligible to be earned based on the extent to which the company achieves adjusted EPS targets (over a minimum threshold) measured on a cumulative basis for the 2017 and 2018 fiscal years, with full vesting of any earned amount on March 3, 2020. For our Adjusted EPS Equity Awards, in this table we have assumed that achievement at 100% of target is the probable outcome of the related performance conditions, which was our assumption on the grant date. With respect to the Adjusted EPS Equity Awards granted for 2017, the aggregate grant date fair value for these awards, assuming the achievement of the highest level of performance (which is 200% of the target unit amount), is $5,464,937 for Mr. Sulentic, $2,999,938 for Mr. Groch, $2,319,935 for Mr. Lafitte, $2,319,935 for Mr. Frese and $2,169,989 for Mr. Concannon. |
(4) | In August 2016, we changed our annual equity grant date from August to March, effective March 2017. As a result, in August 2016, our executives received a stub grant, consisting solely of a Time Vesting Equity Award equal to 50% of their target annual long-term incentive award value (as set forth in the table above). In March 2017, we continued our normal practice of granting a combination of Time Vesting Equity Awards and Adjusted EPS Equity Awards. The March 2017 grant for Messrs. Groch, Lafitte, Frese and Concannon was awarded at the normal target grant value, with 50% in the form of a Time Vesting Equity Award and 50% in the form of an Adjusted EPS Equity Award to maintain the two-thirds time-based, one-third performance-based mix for the combined August 2016 and March 2017 awards. |
(5) | Our one-time Strategic Equity Awards were made and governed by the 2017 Equity Incentive Plan, as described under Summary of Plans, Programs and Agreements on page 60, and include (i) Time Vesting Strategic Equity Awards in the amount of 42,448 restricted stock units that were granted to each of Messrs. Groch, Lafitte, Frese and Concannon, which are scheduled to vest on December 1, 2023, (ii) Relative TSR (rTSR) Strategic Equity Awards with a target unit amount equal to 42,448 restricted stock units that were granted to each of Messrs. Groch, Lafitte, Frese and Concannon, which are eligible to be earned based on measuring the cumulative total stockholder return (TSR) of the company against the cumulative TSR of each of the other companies comprising the S&P 500 on December 1, 2017 (the Comparison Group) with a minimum threshold over a six-year measurement period, with full vesting of any earned amount no later than 60 days after December 1, 2023 and (iii) Relative EPS (rEPS) Strategic Equity Awards with a target unit amount equal to 42,448 restricted stock units that were granted to each of Messrs. Groch, Lafitte, Frese and Concannon, which are eligible to be earned based on measuring the cumulative Adjusted EPS growth of the company against the cumulative EPS growth, as reported under GAAP (GAAP EPS), of each of the other members of the Comparison Group with a minimum threshold over a six-year measurement period, with full vesting of any earned amount no later than 90 days after December 31, 2023. For our rTSR Strategic Equity Awards in this table, we have assumed based on a Monte Carlo simulation that achievement at 107.5% of target is the probable outcome of the related performance conditions, which was our assumption on the grant date. For our rEPS Strategic Equity Awards, in this table we have assumed that achievement at 100% of target is the probable outcome of the related performance conditions, which was our assumption on the grant date. With respect to the (i) rTSR Strategic Equity Awards granted in 2017, the aggregate grant date fair value for these awards, assuming the achievement of the highest level of performance (which is 175% of the target unit amount), is $3,208,326 for each of Messrs. Groch, Lafitte, Frese and Concannon and (ii) rEPS Strategic Equity Awards granted in 2017, the aggregate grant date fair value for these awards, assuming the achievement of the highest level of performance (which is 175% of the target unit amount), is $3,208,326 for each of Messrs. Groch, Lafitte, Frese and Concannon. |
(6) | The amounts in this column represents the sum of each named executive officers annual equity award and, if applicable, one-time Strategic Equity Award, in each case as reported in the two columns to the immediate left of this column. |
(7) | Amounts in this column relate to compensation pursuant to our annual performance award plans referred to in this Proxy Statement as the EIP and EBP, which are described below under Summary of Plans, Programs and Agreements on page 60. Amounts reflected in this table generally are based on the achievement of financial and strategic performance objectives that are established at the beginning of each fiscal year and that are further described under the heading Compensation Discussion and AnalysisComponents of Our ProgramElements of our compensation program beginning on page 40 and Grants of Plan-Based Awards on page 56. |
(8) | The amounts in this column for each of Messrs. Sulentic, Groch, Lafitte, Frese and Concannon reflect our matching contributions to their 401(k) accounts pursuant to our employee 401(k) match policy based on their respective contributions to such accounts. |
(9) | In 2017, the Board set Mr. Sulentics long-term equity award at $5,630,000. After his 2017 annual equity award had been established by our Board, Mr. Sulentic requested, and our Board agreed, to reduce his award by $500,000. Therefore, Mr. Sulentics actual annual equity award for 2017 was $5,130,000, an increase of $1,005,000 over the prior year. Two-thirds of the incremental increase to Mr. Sulentics annual equity award was granted in the form of an Adjusted EPS Equity Award and one-third was granted in the form of a Time Vesting Equity Award. With respect to the remaining $4,125,000 portion of his annual equity award, 50% was granted in the form of an Adjusted EPS Equity Award and the other 50% was granted in the form of a Time Vesting Equity Award. |
(10) | Mr. Sulentic declined the Compensation Committees offer of a one-time Strategic Equity Award. |
(11) | Mr. Concannon became retirement-eligible in November 2017. For additional information regarding the treatment of his outstanding equity awards upon retirement, please refer to the discussion under Severance Plan; Treatment of Death, Disability and Retirement Under 2014, 2015, 2016 and 2017 Equity Award Agreements; Treatment of Qualifying Termination and Retirement Under Strategic Equity Award Agreements beginning on page 63. |
Employment Agreements
None of our named executive officers for 2017 are parties to an employment agreement.
CBRE - 2018 Proxy Statement | 55 |
EXECUTIVE COMPENSATION
Grants of Plan-Based Awards
The following table sets forth information concerning stock and cash awards in respect of the fiscal year ended December 31, 2017 to the persons named in the table under the heading Summary Compensation Table, which awards were granted pursuant to our 2012 Equity Incentive Plan, 2017 Equity Incentive Plan, Executive Incentive Plan or Executive Bonus Plan described below under Summary of Plans, Programs and Agreements on page 60.
Name | Grant Date |
Estimated Future Payouts Under Non-Equity Incentive Plan Awards(1) |
Estimated Future Payouts Under Equity Incentive Plan Awards |
All Other Stock Awards: Number of Shares of Stock or Units (#) |
Grant Date Fair Value of Stock and Option Awards(2)(3) ($) |
|||||||||||||||||||||||||||||||||||
Threshold ($) |
Target ($) |
Maximum ($) |
Threshold (#) |
Target (#) |
Maximum (#) |
|||||||||||||||||||||||||||||||||||
Robert E. Sulentic |
|
|
|
|
1,980,000 |
|
|
3,960,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||||||||||||
|
03/03/17(4) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
65,811 |
|
|
2,397,495 |
(9) | ||||||||||||||
|
03/03/17(5) |
|
|
|
|
|
|
|
|
|
|
|
37,503 |
|
|
75,006 |
|
|
150,012 |
|
|
|
|
|
2,732,469 |
(9) | ||||||||||||||
James R. Groch |
|
|
|
|
1,155,000 |
|
|
2,310,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||||||||||||
|
03/03/17(4) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
41,174 |
|
|
1,499,969 |
| ||||||||||||||
|
03/03/17(5) |
|
|
|
|
|
|
|
|
|
|
|
20,587 |
|
|
41,174 |
|
|
82,348 |
|
|
|
|
|
1,499,969 |
| ||||||||||||||
|
12/01/17(6) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
42,448 |
|
|
1,833,329 |
| ||||||||||||||
|
12/01/17(7) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
45,631 |
|
|
74,284 |
|
|
|
|
|
1,970,803 |
| ||||||||||||||
|
12/01/17(8) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
42,448 |
|
|
74,284 |
|
|
|
|
|
1,833,329 |
| ||||||||||||||
Michael J. Lafitte |
|
|
|
|
1,050,000 |
|
|
2,100,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||||||||||||
|
03/03/17(4) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
31,841 |
|
|
1,159,968 |
| ||||||||||||||
|
03/03/17(5) |
|
|
|
|
|
|
|
|
|
|
|
15,920 |
|
|
31,841 |
|
|
63,682 |
|
|
|
|
|
1,159,968 |
| ||||||||||||||
|
12/01/17(6) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
42,448 |
|
|
1,833,329 |
| ||||||||||||||
|
12/01/17(7) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
45,631 |
|
|
74,284 |
|
|
|
|
|
1,970,803 |
| ||||||||||||||
|
12/01/17(8) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
42,448 |
|
|
74,284 |
|
|
|
|
|
1,833,329 |
| ||||||||||||||
Calvin W. Frese, Jr. |
|
|
|
|
1,050,000 |
|
|
2,100,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||||||||||||
|
03/03/17(4) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
31,841 |
|
|
1,159,968 |
| ||||||||||||||
|
03/03/17(5) |
|
|
|
|
|
|
|
|
|
|
|
15,920 |
|
|
31,841 |
|
|
63,682 |
|
|
|
|
|
1,159,968 |
| ||||||||||||||
|
12/01/17(6) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
42,448 |
|
|
1,833,329 |
| ||||||||||||||
|
12/01/17(7) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
45,631 |
|
|
74,284 |
|
|
|
|
|
1,970,803 |
| ||||||||||||||
|
12/01/17(8) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
42,448 |
|
|
74,284 |
|
|
|
|
|
1,833,329 |
| ||||||||||||||
William F. Concannon(10) |
|
|
|
|
1,000,000 |
|
|
2,000,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||||||||||||
|
03/03/17(4) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
29,783 |
|
|
1,084,995 |
| ||||||||||||||
|
03/03/17(5) |
|
|
|
|
|
|
|
|
|
|
|
14,891 |
|
|
29,783 |
|
|
59,566 |
|
|
|
|
|
1,084,995 |
| ||||||||||||||
|
12/01/17(6) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
42,448 |
|
|
1,833,329 |
| ||||||||||||||
|
12/01/17(7) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
45,631 |
|
|
74,284 |
|
|
|
|
|
1,970,803 |
| ||||||||||||||
|
12/01/17(8) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
42,448 |
|
|
74,284 |
|
|
|
|
|
1,833,329 |
|
(1) | For our executives to be eligible to receive a non-equity incentive plan (EBP) award based on our financial performance in 2017, as measured by adjusted EBITDA, our performance had to exceed 70% of the applicable adjusted EBITDA goal. The maximum award permitted under the EBP was 200% of the executives target. Upon achievement just over the 70% threshold (e.g., 70.0000001%), the amount of the EBP award payable would be negligible, and as such no amount is shown in the Threshold column. For a full description of our EBP awards, see Compensation Discussion and AnalysisComponents of Our ProgramElements of our compensation program beginning on page 40. |
(2) | The amounts shown represent the grant date fair value of the awards computed in accordance with ASC 718. For our Adjusted EPS Equity Awards and rEPS Strategic Equity Awards granted in 2017, in this table we have assumed that achievement at 100% of target is the probable outcome of the related performance conditions, which was our assumption on the grant date. For our rTSR Strategic Equity Awards granted in 2017, in this table we have assumed based on a Monte Carlo simulation that achievement at 107.5% of target is the probable outcome of the related performance conditions, which was our assumption on the grant date. See Note 2 Significant Accounting Policies and Note 13 Employee Benefit Plans to our consolidated financial statements as reported in our Annual Report on Form 10-K for the fiscal year ended December 31, 2017 for a discussion of the valuation of our stock awards. Our 2017 stock awards are further described under the heading Compensation Discussion and AnalysisComponents of Our ProgramElements of our compensation program beginning on page 40. |
(3) | The closing price of our common stock on March 3, 2017 was $36.43 per share and on December 1, 2017 was $43.19 per share. |
(4) | Represents Time Vesting Equity Awards of restricted stock units that were granted to each of Messrs. Sulentic, Groch, Lafitte, Frese and Concannon, which are scheduled to vest 25% per year over four years (on each of March 3, 2018, 2019, 2020 and 2021). |
56 | CBRE - 2018 Proxy Statement |
EXECUTIVE COMPENSATION
(5) | Represents Adjusted EPS Equity Awards of restricted stock units that were granted to each of Messrs. Sulentic, Groch, Lafitte, Frese and Concannon, which are eligible to be earned based on our achievement against certain adjusted EPS targets (over a minimum threshold) as measured on a cumulative basis for the 2017 and 2018 fiscal years, with full vesting of any earned amount on March 3, 2020. Amounts shown in the Threshold column represent the number of shares (50% of the target unit amount) that would be issued upon achievement of the adjusted EPS performance measure at the minimum adjusted EPS threshold level. Amounts shown in the Target column represent the number of shares (100% of the target unit amount) that would be issued upon achievement of the target adjusted EPS performance measure. Amounts shown in the Maximum column represent the number of shares (200% of the target unit amount) that would be issued upon achievement of the adjusted EPS performance measure at the highest level. There is linear interpolation between the various adjusted EPS performance targets. |
(6) | Represents Time Vesting Strategic Equity Awards of restricted stock units that were granted to each of Messrs. Groch, Lafitte, Frese and Concannon, which are scheduled to vest on December 1, 2023. |
(7) | Represents rTSR Strategic Equity Awards of restricted stock units that were granted to each of Messrs. Groch, Lafitte, Frese and Concannon, which are eligible to be earned based on measuring the cumulative TSR of the company against the cumulative TSR of each of the other companies in the Comparison Group with a minimum threshold over a six-year measurement period, with full vesting of any earned amount no later than 60 days after December 1, 2023. Upon achievement just over the 50% threshold (e.g., 50.0000001%), the amount of the rTSR Strategic Equity Award payable would be negligible, and as such no amount is shown in the Threshold column. Amount shown in the Target columns represent the number of shares (107.5% of the target unit amount) that would be issued upon achievement of the target TSR performance measure. Amounts shown in the Maximum column represent the number of shares (175% of the target unit amount) that would be issued upon achievement of the target TSR performance measure at the highest level. There is linear interpolation between the Minimum and Maximum TSR performance targets for this award. |
(8) | Represents rEPS Strategic Equity Awards of restricted stock units that were granted to each of Messrs. Groch, Lafitte, Frese and Concannon, which are eligible to be earned based on measuring the cumulative EPS growth, as reported under GAAP EPS, of each of the other members of the Comparison Group with a minimum threshold over a six-year measurement period, with full vesting of any earned amount no later than 90 days after December 31, 2023. Upon achievement just over the 50% threshold (e.g., 50.0000001%), the amount of the rEPS Strategic Equity Award payable would be negligible, and as such no amount is shown in the Threshold column. Amount shown in the Target columns represent the number of shares (100% of the target unit amount) that would be issued upon achievement of the target TSR performance measure. Amounts shown in the Maximum column represent the number of shares (175% of the target unit amount) that would be issued upon achievement of the target TSR performance measure at the highest level. There is linear interpolation between the Minimum and Maximum EPS performance targets for this award. |
(9) | In 2017, the Board set Mr. Sulentics annual equity award at $5,630,000. After his annual award had been established by our Board, Mr. Sulentic requested, and our Board agreed, to reduce his award by $500,000. Therefore, Mr. Sulentics actual annual equity award for 2017 was $5,130,000, an increase of $1,005,000 over the prior year. Two-thirds of the incremental increase to Mr. Sulentics annual equity award was granted in the form of an Adjusted EPS Equity Award and one-third was granted in the form of a Time Vesting Equity Award. With respect to the remaining $4,125,000 portion of his annual equity award, 50% was granted in the form of an Adjusted EPS Equity Award and the other 50% was granted in the form of a Time Vesting Equity Award. |
(10) | Mr. Concannon became retirement-eligible in November 2017. For additional information regarding the treatment of his outstanding equity awards upon retirement, please refer to the discussion under Severance Plan; Treatment of Death, Disability and Retirement Under 2014, 2015, 2016 and 2017 Equity Award Agreements; Treatment of Qualifying Termination and Retirement Under Strategic Equity Award Agreements beginning on page 63. |
CBRE - 2018 Proxy Statement | 57 |
EXECUTIVE COMPENSATION
Outstanding Equity Awards at Fiscal Year-End
The following table sets forth information concerning unexercised stock options and other equity awards that remain unvested as of December 31, 2017 that are held by the persons named in the table under the heading Summary Compensation Table.
Name
|
Option Awards
|
Stock Awards
|
||||||||||||||||||||||||||||||||||
Number of Securities Underlying Unexercised Options (#) Exercisable
|
Number of Securities Underlying Unexercised Options (#) Unexercisable
|
Option Exercise Price ($)
|
Option Date
|
Number of Shares or Units of Stock That Have Not Vested(1)(2) (3)(4)(5) (#)
|
Market Value of Shares or Units of Stock That Have Not Vested(6) ($)
|
Equity Incentive Unearned Shares, Units or Have Not Vested(7)(8)(9)(10) (#)
|
Equity Incentive Shares, Units or That Have Not Vested(6) ($)
|
|||||||||||||||||||||||||||||
Robert E. Sulentic
|
|
|
|
|
|
|
|
|
|
|
|
|
|
173,970
|
|
|
7,534,641
|
|
|
136,197
|
|
|
5,898,692
|
| ||||||||||||
James R. Groch
|
|
|
|
|
|
|
|
|
|
|
|
|
|
162,136
|
|
|
7,022,110
|
|
|
170,571
|
|
|
7,387,430
|
| ||||||||||||
Michael J. Lafitte
|
|
|
|
|
|
|
|
|
|
|
|
|
|
135,718
|
|
|
5,877,947
|
|
|
151,152
|
|
|
6,546,393
|
| ||||||||||||
Calvin W. Frese, Jr.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
133,902
|
|
|
5,799,296
|
|
|
150,113
|
|
|
6,501,394
|
| ||||||||||||
William F. Concannon(11)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
124,563
|
|
|
5,394,824
|
|
|
145,087
|
|
|
6,283,718
|
|
(1) | With respect to the total number of unvested stock units listed in this column, 20,207, 14,549, 11,963, 11,639 and 8,622 unvested stock units granted on August 14, 2014 (as Time Vesting Equity Awards) to Messrs. Sulentic, Groch, Lafitte, Frese and Concannon, respectively, are scheduled to vest in full on August 14, 2018. |
(2) | With respect to the total number of unvested stock units listed in this column, 36,165, 26,302, 20,340, 19,726 and 17,973 unvested stock units granted on August 13, 2015 (as Time Vesting Equity Awards) to Messrs. Sulentic, Groch, Lafitte, Frese and Concannon, respectively, will vest in equal increments on each of August 14, 2018 and 2019. |
(3) | With respect to the total number of unvested stock units listed in this column, 51,787, 37,663, 29,126, 28,248 and 25,737 unvested stock units granted on August 11, 2016 (as Time Vesting Equity Awards) to Messrs. Sulentic, Groch, Lafitte, Frese and Concannon, respectively, will vest in equal increments on each of August 11, 2018, 2019 and 2020. |
(4) | With respect to the total number of unvested stock units listed in this column, 65,811, 41,174, 31,841, 31,841 and 29,783 unvested stock units granted on March 3, 2017 (as Time Vesting Equity Awards) to Messrs. Sulentic, Groch, Lafitte, Frese and Concannon, respectively, will vest in equal increments on each of March 3, 2018, 2019, 2020 and 2021. For a full description of these awards, see Compensation Discussion and AnalysisComponents of Our ProgramElements of our compensation program beginning on page 40. |
(5) | With respect to the total number of unvested stock units listed in this column, 42,448 unvested stock units granted on December 1, 2017 (as Time Vesting Strategic Equity Awards) to Messrs. Groch, Lafitte, Frese and Concannon, respectively, will vest on December 1, 2023. For a full description of these awards, see Compensation Discussion and AnalysisComponents of Our ProgramElements of our compensation program beginning on page 40. |
(6) | Amounts reflected in this column were calculated by multiplying the number of unvested stock units by $43.31, which was the per-share closing price of our common stock on December 29, 2017. For the Adjusted EPS Equity Awards, rTSR Strategic Equity Awards and rEPS Strategic Equity Awards, these figures assume that those awards are later issued at their target number of shares, except for the Adjusted EPS Equity Awards granted in 2015. As described below in footnote (7) to this table, the 2015 Adjusted EPS Equity Awards will be issued at a greater number of shares than their target (169.2% of target), and we have reflected the greater number of shares in this table. |
(7) | With respect to the performance-based non-vested stock units listed in this column, 36,165, 26,301, 20,340, 19,726 and 17,972 stock units granted on August 13, 2015 (as 2015 Adjusted EPS Equity Awards) to each of Messrs. Sulentic, Groch, Lafitte, Frese and Concannon, respectively, were eligible to be earned based on our achievement against certain adjusted EPS performance targets (over a minimum threshold) as measured on a cumulative basis for the 2016 and 2017 fiscal years, with full vesting of any earned amount on August 14, 2018. The 2015 Adjusted EPS Equity Awards were granted with a target number of restricted stock units, zero to 200% of which could be earned based on our achievement against the various adjusted EPS targets over the performance period. On February 16, 2018, the Compensation Committee certified the companys cumulative adjusted EPS performance for the performance period at $5.01, versus a cumulative adjusted EPS target in those grants of $4.83. As such, Messrs. Sulentic, Groch, Lafitte, Frese and Concannon will vest on August 14, 2018 into 61,191, 44,501, 34,415, 33,376 and 30,408 shares (169.2% of their target number of restricted stock units), respectively, subject to forfeiture in certain circumstances as set forth in their award agreement. We have reflected this greater number of shares in this table. |
(8) | With respect to the performance-based non-vested stock units listed in this column, 75,006, 41,174, 31,841, 31,841 and 29,783 stock units granted on March 3, 2017 (as Adjusted EPS Equity Awards) to each of Messrs. Sulentic, Groch, Lafitte, Frese and Concannon, respectively, are eligible to be earned based on our achievement against certain adjusted EPS performance targets (over a minimum threshold) as measured on a cumulative basis for the 2017 and 2018 fiscal years, with full vesting of any earned amount on March 3, 2020. The Adjusted EPS Equity Award was granted with a target number of restricted stock units, zero to 200% of which may be earned based on our achievement against the various adjusted EPS targets over the performance period. |
(9) | With respect to the performance-based non-vested stock units listed in this column, 42,448 stock units granted on December 1, 2017 (as rTSR Strategic Equity Awards) to each of Messrs. Groch, Lafitte, Frese and Concannon are eligible to be earned based on our achievement against certain total shareholder return targets (over a minimum threshold) over a six-year measurement period, with full vesting of any earned amount no later than 60 days after December 1, 2023. The rTSR Strategic Equity Awards were granted with a target number of restricted stock units, zero to 175% of which may be earned based on our achievement against certain total shareholder return targets over the performance period. |
58 | CBRE - 2018 Proxy Statement |
EXECUTIVE COMPENSATION
(10) | With respect to the performance-based non-vested stock units listed in this column, 42,448 stock units granted on December 1, 2017 (as rEPS Strategic Equity Awards) to each of Messrs. Groch, Lafitte, Frese and Concannon are eligible to be earned based on our achievement against adjusted EPS targets (over a minimum threshold) over a six-year measurement period, with full vesting of any earned amount no later than 90 days after December 31, 2023. The rEPS Strategic Equity Awards were granted with a target number of restricted stock units, zero to 175% of which may be earned based on our achievement against certain adjusted EPS targets over the performance period. |
(11) | Mr. Concannon became retirement-eligible in November 2017. For additional information regarding the treatment of his outstanding equity awards upon retirement, please refer to the discussion under Severance Plan; Treatment of Death, Disability and Retirement Under 2014, 2015, 2016 and 2017 Equity Award Agreements; Treatment of Qualifying Termination and Retirement Under Strategic Equity Award Agreements beginning on page 63. |
Option Exercises and Stock Vested
The following table sets forth information concerning stock option exercises and vesting of stock awards during the fiscal year ended December 31, 2017 for the persons named in the table under Summary Compensation Table. The dollar amounts in the table below are based on the market value of our common stock on the respective dates of vesting multiplied by the number of shares that vested on such date.
Name
|
Option Awards
|
Stock Awards
|
||||||||||||||||||
Number of Shares Acquired on Exercise (#)
|
Value Realized on Exercise ($)
|
Number of Shares Acquired on Vesting (#)
|
Value Realized on Vesting ($)
|
|||||||||||||||||
Robert E. Sulentic
|
|
|
|
|
|
|
|
161,761
|
|
|
5,825,128
|
| ||||||||
James R. Groch
|
|
|
|
|
|
|
|
114,641
|
|
|
4,128,321
|
| ||||||||
Michael J. Lafitte
|
|
|
|
|
|
|
|
95,881
|
|
|
3,452,820
|
| ||||||||
Calvin W. Frese, Jr.
|
|
|
|
|
|
|
|
93,228
|
|
|
3,357,288
|
| ||||||||
William F. Concannon |
|
|
|
|
|
|
|
71,175 |
|
|
2,562,827 |
|
CEO Pay Ratio
CBRE - 2018 Proxy Statement | 59 |
EXECUTIVE COMPENSATION
Summary of Plans, Programs and Agreements
2017 Equity Incentive Plan
2012 Equity Incentive Plan
Second Amended and Restated 2004 Stock Incentive Plan
Executive Incentive Plan (EIP)
60 | CBRE - 2018 Proxy Statement |
EXECUTIVE COMPENSATION
Executive Bonus Plan (EBP)
CBRE - 2018 Proxy Statement | 61 |
EXECUTIVE COMPENSATION
Deferred Compensation Plan (DCP)
401(k) Plan
62 | CBRE - 2018 Proxy Statement |
EXECUTIVE COMPENSATION
Severance Plan; Treatment of Death, Disability and Retirement Under 2014, 2015, 2016 and 2017 Equity Award Agreements; Treatment of Qualifying Termination and Retirement Under Strategic Equity Award Agreements
CBRE - 2018 Proxy Statement | 63 |
EXECUTIVE COMPENSATION
64 | CBRE - 2018 Proxy Statement |
EXECUTIVE COMPENSATION
Hypothetical December 29, 2017 Termination under our Severance Plan
In the hypothetical event that any of our named executive officers for 2017 incurred a Qualifying Termination on December 29, 2017, they would have received the following severance benefits under the Severance Plan in the case of each of our named executive officers:
Name
|
Cash Severance ($)
|
Pro-Rata
|
Accelerated ($)
|
Health and ($)
|
Total* ($)
|
|||||||||||||||||
Robert E. Sulentic |
No Change in Control |
|
5,940,000 |
(4) |
|
2,485,824 |
|
|
11,951,654 |
|
|
20,929 |
|
|
20,398,407 |
| ||||||
During Change in Control Protection Period
|
|
5,940,000
|
(4)
|
|
2,485,824
|
|
|
13,433,333
|
|
|
20,929
|
|
|
21,880,086
|
| |||||||
James R. Groch |
No Change in Control |
|
2,887,500 |
(5) |
|
1,586,512 |
|
|
7,076,508 |
|
|
25,255 |
|
|
11,575,775 |
| ||||||
During Change in Control Protection Period
|
|
2,887,500
|
(5)
|
|
1,586,512
|
|
|
8,894,272
|
|
|
25,255
|
|
|
13,393,539
|
| |||||||
Michael J. Lafitte |
No Change in Control |
|
2,625,000 |
(5) |
|
1,480,560 |
|
|
5,503,315 |
|
|
26,466 |
|
|
9,635,341 |
| ||||||
During Change in Control Protection Period
|
|
2,625,000
|
(5)
|
|
1,480,560
|
|
|
6,909,071
|
|
|
26,466
|
|
|
11,041,097
|
| |||||||
Calvin W. Frese, Jr. |
No Change in Control |
|
2,625,000 |
(5) |
|
1,305,920 |
|
|
5,395,387 |
|
|
20,929 |
|
|
9,347,236 |
| ||||||
During Change in Control Protection Period
|
|
2,625,000
|
(5)
|
|
1,305,920
|
|
|
6,785,421
|
|
|
20,929
|
|
|
10,737,270
|
| |||||||
William F. Concannon
|
No Change in Control |
|
2,550,000 |
(5) |
|
1,415,400 |
|
|
4,875,407 |
|
|
20,929 |
|
|
8,861,736 |
| ||||||
During Change in Control Protection Period
|
|
2,550,000
|
(5)
|
|
1,415,400
|
|
|
6,163,273
|
|
|
20,929
|
|
|
10,149,602
|
|
* | Figures in this table assume no reduction in severance benefits due to operation of Internal Revenue Code 280G. |
(1) | Represents the actual annual cash bonus award for 2017. Includes supplemental and discretionary bonus awards made under EBP for 2017. |
(2) | Amounts shown are calculated by aggregating the sums determined by multiplying, for each outstanding unvested equity award (excluding the one-time Strategic Equity Awards, which are not subject to the Severance Plan), (x) the number of unvested stock units accelerating as a result of the Qualifying Termination (a portion of which may be subject to deferred delivery and continued compliance with restrictive conditions as described above), by (y) our per-share closing stock price on December 29, 2017 of $43.31. The value of accelerated Adjusted EPS Equity Awards is calculated assuming that the applicable performance measures are achieved at their target unit amount, except for our Adjusted EPS Equity Awards granted in 2015 (in which latter case we have assumed that those 2015 awards would have been achieved based on our actual adjusted EPS performance as later certified by our Compensation Committee on February 16, 2018). See footnote (7) to our Outstanding Equity Awards at Fiscal Year-End table on page 58. See the discussion under the heading Qualifying Termination or Retirement Under Strategic Equity Award Agreements below for the treatment of Strategic Equity Awards under the applicable termination events. |
(3) | Represents the approximate value of continued health-care coverage at active employee rates for a period of 18 months and the approximate value of outplacement assistance for 12 months. |
(4) | Represents a lump-sum cash payment equal to two times (2x) the sum of (a) the annual base salary plus (b) the target annual cash bonus award for 2017. |
(5) | Represents a lump-sum cash payment equal to one-and-a-half times (1.5x) the sum of (a) the annual base salary plus (b) the target annual cash bonus award for 2017. |
Death, Disability and Retirement Under 2014, 2015, 2016 and 2017 Annual Equity Award Agreements
CBRE - 2018 Proxy Statement | 65 |
EXECUTIVE COMPENSATION
Hypothetical December 29, 2017 Termination Due to Death, Disability or Retirement
In the hypothetical event that any of our named executive officers during 2017 had terminated employment on December 29, 2017 due to death, disability or retirement under the circumstances covered by our 2014, 2015, 2016 and 2017 annual award agreements, they would have received (either immediately or over time, depending on the circumstances of the termination) the following in respect of their unvested 2014, 2015, 2016 and 2017 annual equity awards:
Name
|
2014 Annual ($)
|
2015 Annual ($)
|
2016 Annual ($)
|
2017 Annual ($)
|
Total ($)
|
|||||||||||||||
Robert E. Sulentic
|
|
875,165
|
|
|
4,216,488
|
|
|
2,242,895
|
|
|
5,046,117
|
|
|
12,380,665
|
| |||||
James R. Groch
|
|
630,117
|
|
|
3,066,478
|
|
|
1,631,185
|
|
|
2,950,906
|
|
|
8,278,686
|
| |||||
Michael J. Lafitte
|
|
518,118
|
|
|
2,371,439
|
|
|
1,261,447
|
|
|
2,282,017
|
|
|
6,433,021
|
| |||||
Calvin W. Frese, Jr.
|
|
504,085
|
|
|
2,299,848
|
|
|
1,223,421
|
|
|
2,282,017
|
|
|
6,309,371
|
| |||||
William F. Concannon(1)
|
|
373,419
|
|
|
2,095,381
|
|
|
1,114,669
|
|
|
2,134,522
|
|
|
5,717,991
|
|
(1) | Mr. Concannon became retirement-eligible in November 2017. |
The foregoing amounts assume (i) the Adjusted EPS Equity Awards granted in 2015 would have been achieved based on our actual adjusted EPS performance as later certified by the Compensation Committee on February 16, 2018, (ii) the Adjusted EPS Equity Awards granted in 2017 are achieved at their target adjusted EPS performance level, (iii) all awards were valued at the closing price of our common stock on December 29, 2017, which was $43.31 per share, and (iv) in the case of retirement, the named executive officer complied with the applicable non-competition, non-solicitation and confidentiality conditions through all applicable vesting dates.
Qualifying Termination or Retirement Under 2017 Strategic Equity Award Agreements
66 | CBRE - 2018 Proxy Statement |
EXECUTIVE COMPENSATION
CBRE - 2018 Proxy Statement | 67 |
EXECUTIVE COMPENSATION
Hypothetical December 29, 2017 Termination Due to Retirement
In the hypothetical event that any of our named executive officers (other than Mr. Sulentic who declined the Compensation Committees offer of a Strategic Equity Award) during 2017 had terminated employment on December 29, 2017 due to retirement and irrespective of whether a change in control of the company had occurred prior to such hypothetical termination, they would not receive any accelerated vesting with respect to their Strategic Equity Awards because such termination would have occurred prior to the first anniversary of the grant date. Accordingly, each named executive officers Strategic Equity Awards would have been forfeited without consideration upon such a hypothetical termination.
Hypothetical December 29, 2017 Termination Due to SEA Qualifying Termination (No Change in Control)
In the hypothetical event that any of our named executive officers (other than Mr. Sulentic, who declined the Compensation Committees offer of a Strategic Equity Award) during 2017 had terminated employment on December 29, 2017 due to a SEA Qualifying Termination, they would have received either immediately or over time, depending on the circumstances of the termination) the following in respect of their Strategic Equity Awards:
Name
|
Time Vesting Strategic ($)
|
rTSR Strategic
|
rEPS Strategic Equity Awards
|
Total
|
||||||||||||
James R. Groch
|
|
24,297
|
|
|
24,297
|
|
|
24,037
|
|
|
72,631
|
| ||||
Michael J. Lafitte
|
|
24,297
|
|
|
24,297
|
|
|
24,037
|
|
|
72,631
|
| ||||
Calvin W. Frese, Jr.
|
|
24,297
|
|
|
24,297
|
|
|
24,037
|
|
|
72,631
|
| ||||
William F. Concannon
|
|
24,297
|
|
|
24,297
|
|
|
24,037
|
|
|
72,631
|
|
The foregoing amounts assume (i) the level of performance achieved for both the rTSR Strategic Equity Awards and the rEPS Strategic Equity Awards will be the level which causes the target number of rTSR Strategic Equity Awards and rEPS Strategic Equity Awards to vest, (ii) all awards were valued at the closing price of our common stock on December 29, 2017, which was $43.31 per share, (iii) the named executive officer complied with the applicable restrictive covenants through all applicable vesting dates, and (iv) for each type of award, the actual number of awards that vested was determined using proration based on service from December 1, 2017 through December 29, 2017.
68 | CBRE - 2018 Proxy Statement |
EXECUTIVE COMPENSATION
Hypothetical December 29, 2017 Termination Due to SEA Qualifying Termination (Change in Control)
In the hypothetical event that a change in control of the company had occurred on December 29, 2017 and any of our named executive officers (other than Mr. Sulentic, who declined the Compensation Committees offer of a Strategic Equity Award) during 2017 had terminated employment due to a SEA Qualifying Termination immediately following such change in control, they would have received (either immediately or over time, depending on the circumstances of the termination) the following in respect of their Strategic Equity Awards:
Name
|
Time Vesting Strategic ($)
|
rTSR Strategic Equity Awards
|
rEPS Strategic Equity Awards
|
Total ($)
|
||||||||||||
James R. Groch
|
|
1,838,423
|
|
|
1,838,423
|
|
|
1,838,423
|
|
|
5,515,269
|
| ||||
Michael J. Lafitte
|
|
1,838,423
|
|
|
1,838,423
|
|
|
1,838,423
|
|
|
5,515,269
|
| ||||
Calvin W. Frese, Jr.
|
|
1,838,423
|
|
|
1,838,423
|
|
|
1,838,423
|
|
|
5,515,269
|
| ||||
William F. Concannon
|
|
1,838,423
|
|
|
1,838,423
|
|
|
1,838,423
|
|
|
5,515,269
|
|
The short time frame between the grant date and the hypothetical change in control date (28 days) does not provide a meaningful measurement period for our rTSR Strategic Equity Awards and rEPS Strategic Equity Awards. Therefore, for purposes of the foregoing table, we have assumed the level of performance achieved for both our rTSR Strategic Equity Awards and our rEPS Strategic Equity Awards will be the level which causes the target number of rTSR Strategic Equity Awards and rEPS Strategic Equity Awards to vest. We have also assumed that (i) all awards were valued at the closing price of our common stock on December 29, 2017, which was $43.31 per share and, for purposes of the rTSR Strategic Equity Awards, that this closing price was also the final value of the companys Class A common stock for purposes of calculating the price per share payable in connection with the change in control and (ii) the named executive officer complied with the applicable restrictive covenants through all applicable vesting dates.
CBRE - 2018 Proxy Statement | 69 |
PROPOSAL 4
CBRE - 2018 Proxy Statement | 71 |
PROPOSAL 4
Required Vote
Approval of this Proposal 4 requires the affirmative vote (i.e., FOR votes) of a majority of the shares outstanding and entitled to vote thereon at our 2018 Annual Meeting. Votes to ABSTAIN and broker non-votes constitute shares outstanding and entitled to vote for purposes of this Proposal, and so a vote to ABSTAIN or a broker non-vote will have the same effect as a vote AGAINST this Proposal.
Recommendation
Our Board strongly recommends that stockholders vote FOR our Proposed Charter Amendment.
Our Board also strongly recommends that stockholders vote AGAINST or ABSTAIN on the Stockholder Proposal.
Voting FOR both our Proposed Charter Amendment and the Stockholder Proposal may invite confusion about stockholders intent. Therefore, we encourage stockholders to vote FOR the Proposed Charter Amendment and to vote AGAINST or ABSTAIN on the Stockholder Proposal.
72 | CBRE - 2018 Proxy Statement |
PROPOSAL 5 STOCKHOLDER PROPOSAL REGARDING SPECIAL STOCKHOLDER MEETINGS
Mr. Chevedden has submitted the following resolution:
Proposal 5Special Shareholder Improvement
Resolved, Shareowners ask our board to take the steps necessary (unilaterally if possible) to amend our by-laws and each appropriate governing document to give holders in the aggregate of 10% of our outstanding common stock the power to call a special shareowner meeting (or the closest percentage to 10% according to state law). This proposal does not impact our boards current power to call a special meeting.
Special meetings allow shareowners to vote on important matters, such as electing new directors that can arise between annual meetings. This proposal topic won more than 70%-support at Edward Lifesciences and SunEdison in 2013.
A shareholder right to call a special meeting and to act by written consent and are 2 complimentary ways to bring an important matter to the attention of both management and shareholders outside the annual meeting cycle as the election of directors. More than 100 Fortune 500 companies provide for shareholders to call special meeting and to act by written consent.
Scores of Fortune 500 companies allow a more functional 10% of shares to call a special meeting compared to the entrenchiment requirement of CBRE Group. CBRE Shareholders do not have the full right to call a special meeting that is available under state law.
This proposal won 52%-support at the CBRE annual meeting. This 52%-support could have been higher (for instance 57%) if small shareholders had the same access to independent corporate governance recommendations as large shareholders.
A shareholder ability to call a special meeting would put shareholders in a better position to ask for improvement in our board of directors at the 2018 annual meeting. For instance, directors could be given more appropriate assignments on our board. Company performance and the stock price can benefit from such improvement.
For example, 5 directors received up to 20-times as many negative votes as other directors:
Brad Freeman
Brandon Boze
Christopher Jenny
Curtis Feeny
Gerardo Lopez
These negative vote directors controlling 80% of our Nomination Committee, 60% of our Executive Pay Committee and 50% of our Audit Committee compounded this disparity.
Plus 3 directors had 16-years long-tenureincluding our Chairman, Ray Wirta.
Long tenure can impair the independence of a director no matter how well qualified.
Independence is a priceless attribute in a director, especially in a Chairman.
Please vote to increase management accountability to shareholders:
Special Shareholder Meeting ImprovementProposal 5
CBRE - 2018 Proxy Statement | 73 |
PROPOSAL 5
74 | CBRE - 2018 Proxy Statement |
PROPOSAL 5
Required Vote
Approval of this Proposal 5 requires the affirmative vote (i.e., FOR votes) of a majority of the shares present or represented and entitled to vote thereon at our 2018 Annual Meeting. A vote to ABSTAIN will count as present for purposes of the vote and so will have the same effect as a vote AGAINST this Proposal. A broker non-vote will not count as present, and so will have no effect in determining the outcome with respect to this Proposal.
Recommendation
Our Board strongly recommends that stockholders vote AGAINST this Stockholder Proposal.
CBRE - 2018 Proxy Statement | 75 |
Security Ownership of Principal Stockholders
Based on information available to us as of March 20, 2018, the only stockholders known to us to beneficially own more than five percent of the outstanding shares of our common stock are (all percentages in the table are based on 339,737,454 shares of common stock outstanding as of March 20, 2018):
Name and Address of Beneficial Owner
|
Amount and Nature of Beneficial Ownership
|
Percent of Class
|
||||||
BlackRock, Inc. |
|
23,251,731 |
(1) |
|
6.8% |
| ||
55 East 52nd Street |
||||||||
New York, New York 10055
|
||||||||
ValueAct Capital Master Fund, L.P. and related entities |
|
19,916,923 |
(2) |
|
5.9% |
| ||
One Letterman Drive, Building D, Fourth Floor |
||||||||
San Francisco, California 94129
|
||||||||
The Vanguard Group |
|
35,065,264 |
(3) |
|
10.3% |
| ||
100 Vanguard Boulevard |
||||||||
Malvern, Pennsylvania 19355
|
(1) | Solely based on information in a Schedule 13G/A filed with the SEC on January 24, 2018 by BlackRock, Inc. The Schedule 13G/A indicates that as of December 31, 2017, BlackRock, Inc. was the beneficial owner of 23,251,731 shares, with sole voting power as to 19,991,683 shares of our common stock and sole dispositive power as to 23,251,731 shares of our common stock. |
(2) | Solely based on information in a Schedule D/A filed with the SEC on March 5, 2018 by ValueAct Capital Master Fund, L.P. and its related entities (ValueAct Group). The Schedule D/A indicates that as of March 1, 2018, ValueAct Group was the beneficial owner of 19,916,923 shares of our common stock. Excluded from this amount are 4,453 restricted stock units vesting within 60 days of March 20, 2018 that are held by Brandon B. Boze for the benefit of the ValueAct Group, as discussed in footnote (6) to the table under Security Ownership of Management and Directors below. |
(3) | Solely based on information in a Schedule 13G/A filed with the SEC on March 12, 2018 by The Vanguard Group. The Schedule 13G/A indicates that as of February 28, 2018, The Vanguard Group was the beneficial owner of 35,065,264 shares, with sole voting power as to 431,907 shares, shared voting power as to 91,058 shares, sole dispositive power as to 34,593,941 shares and shared dispositive power as to 471,323 shares of our common stock. |
76 | CBRE - 2018 Proxy Statement |
STOCK OWNERSHIP
Security Ownership of Management and Directors
The following table below sets forth information as of the close of business on March 20, 2018 regarding the beneficial ownership of our common stock by: (i) each of our current directors and each nominee for director to our Board; (ii) each of our executive officers named in the Summary Compensation Table; and (iii) all current directors, director nominees and current executive officers as a group. Unless otherwise noted, the beneficial owners exercise sole voting and/or investment power over their shares. All percentages in the table are based on 339,737,454 shares of common stock outstanding as of March 20, 2018.
Name
|
Common Stock
|
Common Stock
|
Total Owned(3)(4)
|
Percentage of
|
||||||||||||
Robert E. Sulentic
|
|
466,443
|
|
|
|
|
|
466,443
|
(5)
|
|
*
|
| ||||
James R. Groch
|
|
287,424
|
|
|
|
|
|
287,424
|
|
|
*
|
| ||||
Michael J. Lafitte
|
|
155,149
|
|
|
|
|
|
155,149
|
|
|
*
|
| ||||
Calvin W. Frese, Jr.
|
|
79,219
|
|
|
|
|
|
79,219
|
|
|
*
|
| ||||
William F. Concannon
|
|
79,482
|
|
|
|
|
|
79,482
|
|
|
*
|
| ||||
Brandon B. Boze
|
|
|
|
|
4,453
|
|
|
4,453
|
(6)
|
|
*
|
| ||||
Beth F. Cobert
|
|
|
|
|
4,453
|
|
|
4,453
|
|
|
*
|
| ||||
Curtis F. Feeny
|
|
45,197
|
|
|
4,453
|
|
|
49,650
|
(7)
|
|
*
|
| ||||
Bradford M. Freeman
|
|
116,458
|
|
|
4,453
|
|
|
120,911
|
(8)
|
|
*
|
| ||||
Christopher T. Jenny
|
|
35,892
|
|
|
4,453
|
|
|
40,345
|
|
|
*
|
| ||||
Gerardo I. Lopez
|
|
10,264
|
|
|
4,453
|
|
|
14,717
|
|
|
*
|
| ||||
Frederic V. Malek
|
|
330,284
|
|
|
4,453
|
|
|
334,737
|
(9)
|
|
*
|
| ||||
Paula R. Reynolds
|
|
7,233
|
|
|
4,453
|
|
|
11,686
|
|
|
*
|
| ||||
Laura D. Tyson
|
|
26,918
|
|
|
4,453
|
|
|
31,371
|
|
|
*
|
| ||||
Ray Wirta
|
|
1,111,339
|
|
|
4,453
|
|
|
1,115,792
|
(10)
|
|
*
|
| ||||
Sanjiv Yajnik
|
|
|
|
|
1,807
|
|
|
1,807
|
|
|
*
|
| ||||
All current directors, director nominees and current executive officers as a group (20 persons)
|
|
2,929,757
|
|
|
46,337
|
|
|
2,976,673
|
|
|
*
|
|
* | Less than 1.0% |
(1) | Includes shares over which the person currently holds or shares voting and/or investment power but excludes interests, if any, in shares held in the CBRE Stock Fund of our 401(k) Plan and the shares listed under Common Stock Acquirable Within 60 Days. |
(2) | Includes shares that are deemed to be beneficially owned by virtue of the individuals right to acquire the shares upon the exercise of outstanding stock options or restricted stock units within 60 days from March 20, 2018. |
(3) | Unless otherwise indicated, each person has sole voting and investment power over the shares reported. |
(4) | Includes interests, if any, in shares held in the CBRE Stock Fund of our 401(k) Plan and the shares listed under the Common Stock Acquirable Within 60 Days column and does not include restricted stock units with restrictions that lapse more than 60 days after March 20, 2018. For more information on such units, see Outstanding Equity Awards at Fiscal Year-End table on page 58. |
(5) | Mr. Sulentic is the direct beneficial owner of 436,443 shares. An additional 30,000 shares are held by the Sulentic Family Foundation. He is a co-trustee of the Sulentic Family Foundation but does not have any pecuniary interest in the shares beneficially owned by the foundation. |
(6) | Under an agreement with ValueAct Capital, Mr. Boze directly holds 4,453 restricted stock units (which vest within 60 days following March 20, 2018) for the benefit of ValueAct Capital Master Fund, L.P. and indirectly for (i) VA Partners I, LLC as General Partner of ValueAct Capital Master Fund, L.P., (ii) ValueAct Capital Management, L.P. as the manager of ValueAct Capital Master Fund, L.P., (iii) ValueAct Capital Management, LLC as General Partner of ValueAct Capital Management, L.P., (iv) ValueAct Holdings, L.P. as the sole owner of the limited partnership interests of ValueAct Capital Management, L.P. and the membership interests of ValueAct Capital Management, LLC and as the majority owner of the membership interests of VA Partners I, LLC and (v) ValueAct Holdings GP, LLC as General Partner of ValueAct Holdings, L.P. Mr. Boze is affiliated with ValueAct Capital Master Fund, L.P. and its related entities (the Value Act Group), but he does not have voting or dispositive power over shares beneficially owned by the ValueAct Group and therefore disclaims beneficial ownership of all shares held by or on behalf of them except to the extent of any pecuniary interest therein. The business address of each of the above named is c/o ValueAct Capital, One Letterman Drive, Building D, Fourth Floor, San Francisco, California 94129. |
(7) | Mr. Feeny is a co-trustee of the 1990 Feeny Family Trust A, which owns 45,197 of the shares reflected. |
(8) | Mr. Freeman is the sole trustee of the Bradford M. Freeman Trust DTD 10/21/1996, as amended, which owns 116,458 of the shares reflected. |
(9) | Mr. Malek is the direct beneficial owner of 262,993 shares. Mr. Malek is the sole trustee of the Frederic V Malek TTEE U/A DTD 06/19/1992 Frederic V Malek Trust, which owns 67,291 of the shares reflected. |
(10) | Mr. Wirta is a co-trustee of the The Wirta Family Trust, which owns 1,111,339 of the shares reflected. |
CBRE - 2018 Proxy Statement | 77 |
STOCK OWNERSHIP
Section 16(a) Beneficial Ownership Reporting Compliance
78 | CBRE - 2018 Proxy Statement |
RELATED-PARTY TRANSACTIONS
80 | CBRE - 2018 Proxy Statement |
GENERAL INFORMATION ABOUT THE ANNUAL MEETING
Voting Instructions and Information
How to attend the Annual Meeting
Matters to be presented
We are not aware of any matters to be presented at the Annual Meeting other than those described in this Proxy Statement. If any matters not described in this Proxy Statement are properly presented at the meeting, then proxies will use their own judgment to determine how to vote your shares. If the meeting is adjourned or postponed, then proxies can vote your shares at the adjournment or postponement as well.
Stockholders entitled to vote
You may vote if you owned shares of our common stock as of March 20, 2018, which is the record date for the Annual Meeting. You are entitled to one vote on each matter presented at the Annual Meeting for each share of common stock that you owned on that date. As of March 20, 2018, we had 339,737,454 shares of common stock outstanding.
Vote tabulation
Broadridge Financial Solutions, Inc., an independent third party, will tabulate the votes, and our Assistant Secretary will act as the inspector of the election.
Confidential voting
Your proxy card, ballot and voting records will not be disclosed to us unless applicable law requires disclosure, you request disclosure or your vote is cast in a contested election (which last exception is not applicable for the 2018 Annual Meeting). If you write comments on your proxy card, then your comments will be provided to us, but how you voted will remain confidential.
How do I vote?
CBRE - 2018 Proxy Statement | 81 |
GENERAL INFORMATION ABOUT THE ANNUAL MEETING
If you do not vote/effect of broker non-votes
Vote levels required to pass an item of business
82 | CBRE - 2018 Proxy Statement |
GENERAL INFORMATION ABOUT THE ANNUAL MEETING
Shares in the 401(k) plan
The Boards voting recommendations
Revoking your proxy
CBRE - 2018 Proxy Statement | 83 |
GENERAL INFORMATION ABOUT THE ANNUAL MEETING
Cost of proxy solicitation
Where you can find our corporate governance materials
Elimination of Paper and Duplicative Materials
84 | CBRE - 2018 Proxy Statement |
GENERAL INFORMATION ABOUT THE ANNUAL MEETING
Incorporation by Reference
Transfer Agent Information
Broadridge Corporate Issuer Solutions, Inc., or Broadridge, is the transfer agent for the common stock of CBRE Group, Inc. Broadridge can be reached at (855) 627-5086 or via email at shareholder@broadridge.com. You should contact Broadridge if you are a registered stockholder and have a question about your account, if your stock certificate has been lost or stolen, or if you would like to report a change in your name or address. Broadridge Corporate Issuer Solutions, Inc. can be contacted as follows:
Regular, Registered or Overnight Mail |
Telephone Inquiries | |
Broadridge Corporate Issuer Solutions, Inc. Attention: Interactive Workflow System 1155 Long Island Avenue Edgewood, New York 11717 |
(855) 627-5086, or TTY for hearing impaired: (855) 627-5080
Foreign Shareowners: (720) 378-5662, or TTY Foreign Shareowners: (720) 399-2074
Website: www.shareholder.broadridge.com |
CBRE - 2018 Proxy Statement | 85 |
RECONCILIATION OF CERTAIN NON-GAAP FINANCIAL
MEASURES
We use non-GAAP financial measures within this Proxy Statement. We provide below reconciliations to their corresponding financial measure computed in accordance with GAAP. As described in our Annual Report on Form 10-K for the fiscal year ended December 31, 2017 our Board and management use non-GAAP financial measures to evaluate our performance and manage our operations. However, non-GAAP financial measures should be viewed in addition to, and not as an alternative for, financial results prepared in accordance with GAAP.
In addition, note that we refer to adjusted EBITDA, adjusted net income and adjusted EPS from time to time in our public reporting as EBITDA, as adjusted, net income attributable to CBRE Group, Inc., as adjusted and diluted income per share attributable to CBRE Group, Inc. shareholders, as adjusted, respectively.
1. | Fee Revenue |
A reconciliation of fee revenue to revenue is shown below (dollars in thousands). Revenue includes client reimbursed pass through costs largely associated with employees that are dedicated to client facilities and subcontracted vendor work performed for clients, both of which are excluded from fee revenue.
Year Ended December 31, | ||||||||
2017 | 2016 | |||||||
Consolidated | ||||||||
Fee revenue(1)
|
$
|
9,389,412
|
|
$
|
8,725,829
|
| ||
Plus: Pass through costs also recognized as revenue
|
|
4,820,196
|
|
|
4,345,760
|
| ||
|
|
|
|
|||||
Revenue
|
$
|
14,209,608
|
|
$
|
13,071,589
|
| ||
|
|
|
|
(1) | Certain adjustments have been made to 2016 fee revenue to conform with current-year presentation. |
2. | Adjusted EBITDA |
A reconciliation of net income computed in accordance with GAAP to adjusted EBITDA for the fiscal years ended December 31, 2017 and 2016 is set forth below (dollars in thousands):
Year Ended December 31, | ||||||||
2017 | 2016 | |||||||
Net income attributable to CBRE Group, Inc.
|
$
|
691,479
|
|
$
|
571,973
|
| ||
Add:
|
||||||||
Depreciation and amortization
|
|
406,114
|
|
|
366,927
|
| ||
Interest expense
|
|
136,814
|
|
|
144,851
|
| ||
Provision for income taxes
|
|
466,147
|
|
|
296,662
|
| ||
Less:
|
||||||||
Interest income
|
|
9,853
|
|
|
8,051
|
| ||
|
|
|
|
|||||
EBITDA
|
|
1,690,701
|
|
|
1,372,362
|
| ||
Adjustments:
|
||||||||
Integration and other costs related to acquisitions
|
|
27,351
|
|
|
125,743
|
| ||
Carried interest incentive compensation reversal to align with the timing of associated revenue
|
|
(8,518
|
)
|
|
(15,558
|
)
| ||
Cost-elimination expenses(1)
|
|
|
|
|
78,456
|
| ||
|
|
|
|
|||||
EBITDA, as adjusted
|
$
|
1,709,534
|
|
$
|
1,561,003
|
| ||
|
|
|
|
(1) | Represents cost-elimination expenses relating to a program initiated in the fourth quarter of 2015 and completed in the third quarter of 2016 to reduce the companys global cost structure after several years of significant revenue and related cost growth. Cost-elimination expenses incurred during the twelve months ended December 31, 2016 consisted of $73.6 million of severance costs related to headcount reductions in connection with the program and $4.9 million of third-party contract termination costs. |
CBRE - 2018 Proxy Statement | A-1 |
3. | Adjusted Net Income and Adjusted EPS |
A reconciliation of net income computed in accordance with GAAP to net income attributable to CBRE Group, Inc., as adjusted (adjusted net income), and to diluted income per share attributable to CBRE Group, Inc. shareholders, as adjusted (adjusted EPS), in each case for the fiscal years ended December 31, 2017 and 2016, is set forth below (dollars in thousands, except share data):
Year Ended December 31, | ||||||||
2017 | 2016 | |||||||
Net income attributable to CBRE Group, Inc.
|
$
|
691,479
|
|
$
|
571,973
|
| ||
Plus / minus:
|
||||||||
Non-cash amortization expense related to certain intangible assets attributable to acquisitions
|
|
112,945
|
|
|
111,105
|
| ||
Integration and other costs related to acquisitions
|
|
27,351
|
|
|
125,743
|
| ||
Carried interest incentive compensation reversal to align with the timing of associated revenue
|
|
(8,518
|
)
|
|
(15,558
|
)
| ||
Cost-elimination expenses(1)
|
|
|
|
|
78,456
|
| ||
Tax impact of adjusted items
|
|
(42,128
|
)
|
|
(93,181
|
)
| ||
Impact of U.S. tax reform
|
|
143,359
|
|
|
|
| ||
|
|
|
|
|||||
Net income attributable to CBRE Group, Inc., as adjusted
|
$
|
924,488
|
|
$
|
778,538
|
| ||
|
|
|
|
|||||
Diluted income per share attributable to CBRE Group, Inc. shareholders, as adjusted
|
$
|
2.71
|
|
$
|
2.30
|
| ||
|
|
|
|
|||||
Weighted average shares outstanding for diluted income per share
|
|
340,783,556
|
|
|
338,424,563
|
| ||
|
|
|
|
(1) | Represents cost-elimination expenses relating to a program initiated in the fourth quarter of 2015 and completed in the third quarter of 2016 to reduce the companys global cost structure after several years of significant revenue and related cost growth. Cost-elimination expenses incurred during the twelve months ended December 31, 2016 consisted of $73.6 million of severance costs related to headcount reductions in connection with the program and $4.9 million of third-party contract termination costs. |
4. | Adjusted EBITDA for our Global Workplace Solutions business |
A reconciliation of net income computed in accordance with GAAP to EBITDA and to EBITDA, as adjusted, for our Global Workplace Solutions business (which we refer to as adjusted EBITDA for our Global Workplace Solutions business) for the fiscal years ended December 31, 2017 and 2016 is set forth below (dollars in thousands):
Year Ended December 31, | ||||||||
2017 | 2016 | |||||||
Net income attributable to CBRE Group, Inc.
|
$
|
390,295
|
|
$
|
311,132
|
| ||
Adjustments:
|
||||||||
Depreciation and amortization
|
|
117,873
|
|
|
119,942
|
| ||
Interest expense, net
|
|
2,024
|
|
|
4,889
|
| ||
Royalty and management service (income) expense
|
|
(14,418
|
)
|
|
16,510
|
| ||
Provision for income taxes
|
|
21,572
|
|
|
2,606
|
| ||
|
|
|
|
|||||
EBITDA
|
|
517,346
|
|
|
455,079
|
| ||
Integration and other costs related to acquisitions
|
|
|
|
|
2,428
|
| ||
|
|
|
|
|||||
EBITDA, as adjusted
|
$
|
517,346
|
|
$
|
457,507
|
| ||
|
|
|
|
A-2 | CBRE - 2018 Proxy Statement |
AMENDED AND RESTATED CERTIFICATE OF
INCORPORATION
(AS PROPOSED TO BE AMENDED BY PROPOSAL 4)
*Blacklined text below indicates changes versus our existing certificate of incorporation. Proposed additions are indicated by double underlining, and proposed deletions are indicated by strike-outs.*
AMENDED AND RESTATED
CERTIFICATE OF INCORPORATION
OF
CBRE GROUP, INC.
CBRE Group, Inc. (the Corporation), a corporation organized and existing under the laws of the State of Delaware, hereby certifies as follows:
A. The name of the Corporation is CBRE Group, Inc. The Corporation was originally incorporated under the name BLUM CB Holding Corp. The Corporations original certificate of incorporation was filed with the Secretary of State of the State of Delaware on February 20, 2001. The Corporation filed Certificates of Amendment of the Certificate of Incorporation with the Secretary of State of the State of Delaware on March 26, 2001 and June 4, 2001 and a Restated Certificate of Incorporation with the Secretary of State of the State of Delaware on June 29, 2001, in each of the foregoing cases under the name CBRE Holding, Inc. The Corporation filed a Certificate of Amendment of the Certificate of Incorporation with the Secretary of State of the State of Delaware on February 13, 2004 changing the name of the Corporation to CB Richard Ellis Group, Inc. The Corporation filed a Restated Certificate of Incorporation with the Secretary of State of the State of Delaware on May 4, 2004, June 7, 2004 and June 16, 2004. The Corporation filed a Certificate of Amendment of Restated Certificate of Incorporation with the Secretary of State of the State of Delaware on June 4, 2009. The Corporation filed a Certificate of Ownership and Merger with the Secretary of State of the State of Delaware on October 3, 2011 changing the name of the Corporation to CBRE Group, Inc. The Corporation filed an Amended and Restated Certificate of Incorporation with the Secretary of State of the State of Delaware on May 13, 2016.
B. This Amended and Restated Certificate of Incorporation, which amends and restates the certificate of incorporation of the Corporation in its entirety, was duly adopted by the Board of Directors and by the stockholders in accordance with Sections 103, 242 and 245 of the General Corporation Law of the State of Delaware.
C. The certificate of incorporation of the Corporation is amended and restated to read in its entirety as follows:
FIRST: The name of the Corporation is CBRE Group, Inc.
SECOND: The registered office and registered agent of the Corporation is The Corporation Trust Company, 1209 Orange Street, Wilmington, New Castle County, Delaware 19801.
THIRD: The purpose of the Corporation is to engage in any lawful act or activity for which corporations may be organized under the General Corporation Law of the State of Delaware (the DGCL).
FOURTH: (1) The total number of shares of all classes of capital stock that the Corporation shall have authority to issue is 550,000,000, consisting of (a) 25,000,000 shares of Preferred Stock, $0.01 par value per share (Preferred Stock), and (b) 525,000,000 shares of Class A common stock, $0.01 par value per share (Common Stock).
(2) The number of authorized shares of Preferred Stock or Common Stock may be increased or decreased (but not below the number of shares thereof then outstanding) by the affirmative vote of the holders of a majority in voting power of the stock of the Corporation entitled to vote thereon irrespective of the provisions of Section 242(b)(2) of the DGCL (or any successor provision thereto), and no vote of the holders of any of the Common Stock or the Preferred Stock voting separately as a class shall be required therefor.
(3) The Board of Directors is hereby expressly authorized, by resolution or resolutions, to provide, out of the unissued shares of Preferred Stock, for series of Preferred Stock and, with respect to each such series, to fix the number of shares constituting such series and the designation of such series, the voting powers (if any) of the shares of such series, and the
CBRE - 2018 Proxy Statement | B-1 |
preferences and relative, participating, optional or other special rights, if any, and any qualifications, limitations or restrictions thereof, of the shares of such series. The powers, preferences and relative, participating, optional and other special rights of each series of Preferred Stock, and the qualifications, limitations or restrictions thereof, if any, may differ from those of any and all other series at any time outstanding.
(4) (a) Each holder of Common Stock, as such, shall be entitled to one vote for each share of Common Stock held of record by such holder on all matters on which stockholders generally are entitled to vote; provided, however, that, except as otherwise provided in Section (2) of this Article Fourth or as otherwise required by law, holders of Common Stock, as such, shall not be entitled to vote on any amendment to this Amended and Restated Certificate of Incorporation (including any certificate of designations relating to any series of Preferred Stock) that relates solely to the terms of one or more outstanding series of Preferred Stock if the holders of such affected series are entitled, either separately or together with the holders of one or more other such series, to vote thereon pursuant to this Amended and Restated Certificate of Incorporation (including any certificate of designations relating to any series of Preferred Stock) or pursuant to the DGCL.
(b) Except as otherwise required by law, holders of a series of Preferred Stock, as such, shall be entitled only to such voting rights, if any, as shall expressly be granted thereto by this Amended and Restated Certificate of Incorporation (including any certificate of designations relating to such series).
(c) Subject to applicable law and the rights, if any, of the holders of any outstanding series of Preferred Stock having a preference over or, the right to participate with, the Common Stock with respect to the payment of dividends, dividends may be declared and paid on the Common Stock at such times and in such amounts as the Board of Directors in its discretion shall determine.
(d) Upon the dissolution, liquidation or winding up of the corporation, subject to the rights, if any, of the holders of any outstanding series of Preferred Stock having a preference over, or the right to participate with, the Common Stock with respect to the distribution of assets of the Corporation upon such dissolution, liquidation or winding up of the Corporation, the holders of the Common Stock, as such, shall be entitled to receive the assets of the Corporation available for distribution to its stockholders ratably in proportion to the number of shares held by them.
FIFTH: In furtherance and not in limitation of the powers conferred by the DGCL, the Board of Directors shall be authorized to make, amend, alter, change, add to or repeal the By-Laws of the Corporation in any manner not inconsistent with the laws of the State of Delaware, subject to the power of the stockholders to amend, alter, change, add to or repeal the By-Laws made by the Board of Directors in the manner set forth in the By-Laws.
SIXTH: To the fullest extent permitted by the laws of the State of Delaware:
(1) (a) The Corporation shall indemnify any person (and such persons heirs, executors or administrators) who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding (brought in the right of the Corporation or otherwise), whether civil, criminal, administrative or investigative, and whether formal or informal, including appeals, by reason of the fact that such person is or was a director or officer of the Corporation or, while a director or officer of the Corporation, is or was serving at the request of the Corporation as a director, officer, partner, member, fiduciary, trustee, employee or agent of another corporation, partnership, joint venture, trust, limited liability company or other enterprise, for and against all expenses (including reasonable attorneys fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by such person or such heirs, executors or administrators in connection with such action, suit or proceeding, including appeals. Notwithstanding the preceding sentence, the Corporation shall be required to indemnify a person described in such sentence in connection with any action, suit or proceeding (or part thereof) commenced by such person only if the commencement of such action, suit or proceeding (or part thereof) by such person was authorized by the Board of Directors. The Corporation may indemnify any person (and such persons heirs, executors or administrators) who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding (brought in the right of the Corporation or otherwise), whether civil, criminal, administrative or investigative, and whether formal or informal, including appeals, by reason of the fact that such person is or was an employee or agent of the Corporation or, while an employee or agent of the Corporation, is or was serving at the request of the Corporation as a director, officer, partner, member, fiduciary, trustee, employee or agent of another Corporation, partnership, joint venture, trust, limited liability company or other enterprise, for and against all expenses (including reasonable attorneys fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by such person or such heirs, executors or administrators in connection with such action, suit or proceeding, including appeals.
(b) The Corporation (i) shall promptly pay expenses incurred by any person described in the first sentence of subsection (a) of this Article Sixth, Section (1) and (ii) may pay expenses incurred by any person whom the Corporation has determined to indemnify pursuant to the third sentence of subsection (a) of this Article Sixth, Section (1), in each case in defending any action, suit or proceeding in advance of the final disposition of such action, suit or proceeding, including appeals, upon presentation of appropriate documentation.
(c) The Corporation may purchase and maintain insurance on behalf of any person described in subsection (a) of this Article Sixth, Section (1) against any liability asserted against such person, whether or not the Corporation would have the power to indemnify such person against such liability under the provisions of this Article Sixth, Section (1) or otherwise.
B-2 | CBRE - 2018 Proxy Statement |
(d) The provisions of this Article Sixth, Section (1) shall be applicable to all actions, claims, suits or proceedings made or commenced after the adoption hereof, whether arising from acts or omissions to act occurring before or after its adoption. The provisions of this Article Sixth, Section (1) shall be deemed to be a contract between the Corporation and each director or officer who serves in such capacity at any time while this Article Sixth, Section (1) and the relevant provisions of the laws of the State of Delaware and other applicable law, if any, are in effect, and any repeal or modification hereof shall not affect any rights or obligations then existing with respect to any state of facts or any action, suit or proceeding then or theretofore existing, or any action, suit or proceeding thereafter brought or threatened based in whole or in part on any such state of facts. If any provision of this Article Sixth, Section (1) shall be found to be invalid or limited in application by reason of any law or regulation, it shall not affect the validity of the remaining provisions hereof. The rights of indemnification provided in this Article Sixth, Section (1) shall neither be exclusive of, nor be deemed in limitation of, any rights to which an officer or director may otherwise be entitled or permitted by contract, this Certificate of Incorporation, vote of stockholders or directors or otherwise, or as a matter of law, both as to actions in such persons official capacity and actions in any other capacity while holding such office, it being the policy of the Corporation that indemnification of any person whom the Corporation is obligated to indemnify pursuant to this Article Sixth, Section (1) shall be made to the fullest extent permitted by law.
(e) For purposes of this Article Sixth, references to other enterprises shall include employee benefit plans; references to fines shall include any excise taxes assessed on a person with respect to an employee benefit plan; and references to serving at the request of the Corporation shall include any service as a director, officer, employee or agent of the Corporation which imposes duties on, or involves services by, such director, officer, employee, or agent with respect to an employee benefit plan, its participants, or beneficiaries.
(2) A director of the Corporation shall not be liable to the Corporation or its stockholders for monetary damages for breach of fiduciary duty as a director, except to the extent such exemption from liability or limitation thereof is not permitted under the Delaware General Corporation Law as the same exists or may hereafter be amended. Any amendment, modification or repeal of the foregoing sentence shall not adversely affect any right or protection of a director of the Corporation hereunder in respect of any act or omission occurring prior to the time of such amendment, modification or repeal.
SEVENTH: (1) The business and affairs of the Corporation shall be managed by or under the direction of a Board of Directors consisting of not less than three directors, the exact number of directors to be determined from time to time by resolution adopted by affirmative vote of a majority of the Board of Directors. A director shall hold office until his or her successor shall be elected and shall qualify, subject, however, to prior death, resignation, retirement, disqualification or removal from office. Any newly created directorship on the Board of Directors that results from an increase in the number of directors and any vacancy occurring in the Board of Directors shall be filled only by a majority of the directors then in office, although less than a quorum, or by a sole remaining director. If any applicable provision of the DGCL expressly confers power on stockholders to fill such a directorship at a special meeting of stockholders, such a directorship may be filled at such a meeting.
(2) Notwithstanding the foregoing, whenever the holders of any one or more series of Preferred Stock issued by the Corporation shall have the right, voting separately as a series or separately as a class with one or more such other series, to elect directors at an annual or special meeting of stockholders, the election, term of office, removal, filling of vacancies and other features of such directorships shall be governed by the terms of this Amended and Restated Certificate of Incorporation (including any certificate of designations relating to any series of Preferred Stock) applicable thereto.
EIGHTH: Except as otherwise required by law and subject to the rights of the holders of any series of Preferred
Stock, special meetings of stockholders of the Corporation (1) shall be called only by the Chair of the Board of Directors, the Chief Executive Officer or the Board of Directors pursuant to a resolution approved by the Board of Directors and
(2) shall be called by the Secretary of the Corporation upon the written request of holder(s) Owning (as defined below) at least 3025% (in the aggregate) of the then
voting power of all shares of the Corporation entitled to vote on the matters to be brought before the proposed special meeting.
In the case of a special meeting of stockholders called pursuant to the foregoing clause (2), the requesting holder(s) must
(i) continue to Own (for the holding period set forth in the By-Laws of the Corporation from time to time) shares representing at least
3025% (in the aggregate) of the then voting power of all shares of the Corporation entitled to vote on the matters to be brought before the proposed special meeting,
(ii) provide information in writing regarding such stockholder(s), their stock ownership and the matters that they request to bring before the proposed special meeting and (iii) comply with procedures and other terms and conditions
relating to special meetings as set forth in the By-Laws of the Corporation from time to time.
For purposes of this Article Eighth, a holder shall be deemed to Own only those shares for which it possesses both (x) full voting and investment rights and (y) a full economic interest (i.e., shares for which the holder has not only the opportunity to profit, but is also exposed to the risk of loss), which terms may be further defined in the By-Laws of the Corporation from time to time.
NINTH: The Corporation hereby elects to be governed by Section 203 of the DGCL, as the same exists or may hereafter be amended.
***
CBRE - 2018 Proxy Statement | B-3 |
IN WITNESS WHEREOF, the undersigned has executed this Amended and Restated
Certificate of Incorporation on this [ ] day of May, 2016.2018.
CBRE GROUP, INC. |
||||
By: |
|
|||
Name: Laurence H. Midler |
||||
Title: Executive Vice President |
B-4 | CBRE - 2018 Proxy Statement |
AMENDED AND RESTATED BY-LAWS
(AS PROPOSED TO BE AMENDED IF
PROPOSAL 4 IS
APPROVED)
*Blacklined text below indicates changes versus our existing by-laws. Proposed additions are indicated by double underlining, and proposed deletions are indicated by strike-outs.*
AMENDED AND RESTATED
BY-LAWS
OF
CBRE GROUP, INC.
(the Corporation)
dated January 11, 2017
As Amended [ ], 2018
ARTICLE I.
STOCKHOLDERS
Section 1. Annual Meeting. The annual meeting of the stockholders of the Corporation for the purpose of electing directors and for the transaction of such other business as may properly be brought before the meeting shall be held on such date, and at such time and place within or without the State of Delaware as may be designated from time to time by the Board of Directors.
Section 2. Special Meeting. (a) Special meetings of the stockholders
(1) shall be called only by the Chair of the Board of Directors, the Chief Executive Officer of the Corporation (the Chief Executive Officer) or the Board of Directors pursuant to a resolution approved by the Board of
Directors and (2) shall be called by the Secretary of the Corporation (the Secretary) upon the written request of holder(s) Owning (as defined below) at least 3025% (in the aggregate) of the then
voting power of all shares of the Corporation entitled to vote on the matters to be brought before the proposed special meeting (the Requisite Percent, and such a special meeting, a Stockholder Requested Special
Meeting); provided that such request shall be invalid if (A) it relates to an item of business that is the same or substantially similar to any item of business that stockholders voted on at a meeting of stockholders that
occurred within 30 days preceding the date of such request or (B) the special-meeting request is received within the period commencing 90 days prior to the anniversary of the date of the most recent annual meeting of stockholders and ending on
the date of the next annual meeting of stockholders. Special meetings of the stockholders shall be held at such time and place within or without the State of Delaware as may be designated from time to time by the Board of Directors; provided
that any Stockholder Requested Special Meeting shall be held within 120 days after the Secretary receives notice that such meeting has been called for.
For purposes of this Article I, Section 2, a holder shall be deemed to Own only those shares for which it possesses both (x) full voting and investment rights and (y) a full economic interest (i.e., shares for which the holder has not only the opportunity to profit, but is also exposed to the risk of loss); provided that the number of shares calculated in accordance with the foregoing clauses (x) and (y) shall not include any shares (A) sold by such person or any of its affiliates in any transaction that has not been settled or closed, (B) borrowed by such holder or any of its affiliates for any purposes or purchased by such holder or any of its affiliates pursuant to an agreement to resell or (C) subject to any option, warrant, forward contract, swap, contract of sale, other derivative or similar agreement entered into by such holder or any of its affiliates, whether any such instrument or agreement is to be settled with shares or with cash based on the notional amount or value of shares of the Corporation entitled to vote at the Stockholder Requested Special Meeting, in any such case which instrument or agreement has, or is intended to have, the purpose or effect of (1) reducing in any manner, to any extent or at any time in the future, such holders or its affiliates full right to vote or direct the voting of any such shares and/or (2) hedging, offsetting or altering to any degree the gain or loss arising from the full economic ownership of such shares by such holder or affiliate. A holder shall
CBRE - 2018 Proxy Statement | C-1 |
Own shares held in the name of a nominee or other intermediary so long as the holder retains the right to instruct how the shares are voted with respect to the election of directors and possesses the full economic interest in the shares. A holders ownership of shares shall be deemed to continue during any period in which the person has delegated any voting power by means of a proxy, power of attorney or other instrument or arrangement that is revocable at any time by the holder. The determination of the extent to which a person Owns shares for these purposes shall be made in good faith by the Board of Directors, which determination shall be conclusive and binding on the Corporation and its stockholders.
(b) In order for the Secretary to call a Stockholder Requested Special Meeting, one or more written requests for a special stockholder meeting (individually or collectively, a Special Meeting Request) signed and dated by the stockholder(s) of record that Own the Requisite Percent, or by persons who are acting on behalf of those who Own the Requisite Percent, must be delivered by the requesting stockholder(s) to the Secretary at the principal executive offices of the Corporation, must set forth therein the purpose or purposes of the proposed Stockholder Requested Special Meeting and must be accompanied by:
(1) the information required by paragraph (B) of Article I, Section 11 of these By-Laws; and
(2) as to each stockholder signing such request, or if such stockholder is a nominee or custodian, as to each beneficial owner on whose behalf such request is signed, (i) an affidavit signed by such person stating the number of shares of the Corporation that it Owns as of the date such request was signed and agreeing to continue to Own at least (A) such number of shares or (B) a number of shares equal to the Requisite Percent through the date of the Stockholder Requested Special Meeting and to update and supplement such affidavit, if necessary, so that the information provided in such affidavit regarding the number of shares that such person Owns shall be true and correct as of the record date for the Stockholder Requested Special Meeting and as of the date that is five business days prior to the meeting or any adjournment or postponement thereof, with such update and supplement to be delivered to the Secretary at the principal executive offices of the Corporation not later than five business days after the record date for the meeting in the case of the update and supplement required to be made as of the record date, and not later than three business days prior to the date for the meeting or any adjournment or postponement thereof in the case of the update and supplement required to be made as of five business days prior to the meeting or any adjournment or postponement thereof; provided that in the event of any decrease in the number of shares of the Corporation Owned by such person at any time before the Stockholder Requested Special Meeting, such persons Special Meeting Request shall be deemed revoked with respect to the shares comprising such reduction and shall not be counted towards the calculation of the Requisite Percent.
One or more written requests for a special meeting delivered to the Secretary shall constitute a valid Special Meeting Request only if each such written request satisfies the requirements set forth above in this clause (b) and has been dated and delivered to the Secretary within 60 days of the earliest dated of such requests. If the record holder is not the signatory to the Special Meeting Request, such Special Meeting Request will not be valid unless documentary evidence from the record holder of such signatorys authority to execute the Special Meeting Request on behalf of the record holder is supplied to the Secretary at the time of delivery of such Special Meeting Request (or within 10 business days thereafter). The determination of the validity of a Special Meeting Request shall be made in good faith by the Board of Directors, whose determination shall be conclusive and binding on the Corporation and the stockholders.
(c) If none of the stockholder(s) who submitted the Special Meeting Request(s) (or their qualified representatives) appears at the Stockholder Requested Special Meeting to present the matter or matters to be brought before the special meeting as specified in the Special Meeting Request(s), the Corporation need not present the matter or matters for a vote at the meeting, notwithstanding that proxies in respect of such vote may have been received by the Corporation.
(d) The stockholder seeking to call the special meeting may revoke a Special Meeting Request by written revocation delivered to, or mailed and received by, the Secretary at any time prior to the special meeting, and any stockholder signing a Special Meeting Request may revoke such request as to the shares that such person Owns (or as to the shares that are Owned by the person on whose behalf the stockholder is acting, as applicable), and their Special Meeting Request shall thereupon be deemed revoked; provided that if as a result of such revocation(s) there are no longer any valid unrevoked Special Meeting Request(s) from stockholders who Own at least a Requisite Percent with respect to the proposed special meeting, then there shall be no requirement for the Secretary to call, or for the Corporation to hold, a special meeting regardless of whether notice of such special meeting has been sent and/or proxies solicited for such special meeting. Further, in the event that the stockholder requesting the Stockholder Requested Special Meeting withdraws such Special Meeting Request, there shall be no requirement for the Secretary to call, or for the Corporation to hold, such special meeting.
Section 3. Notice. Except as otherwise provided by law, notice of the time, place and, in the case of a special meeting, the purpose or purposes of the meeting of stockholders shall be delivered personally or mailed not earlier than sixty, nor less than ten, days previous thereto, to each stockholder of record entitled to vote at the meeting at such address as appears on the records of the Corporation.
Section 4. Quorum. The holders of a majority in voting power of the stock issued and outstanding and entitled to vote thereat, present in person or represented by proxy, shall constitute a quorum at all meetings of the stockholders for the transaction of business, except as otherwise provided by statute or by the Corporations Amended and Restated Certificate of
C-2 | CBRE - 2018 Proxy Statement |
Incorporation as may be amended from time to time (the Certificate of Incorporation); but if at any regularly called meeting of stockholders there shall be less than a quorum present, the stockholders present may adjourn the meeting from time to time without further notice other than announcement at the meeting until a quorum shall be present or represented. At such adjourned meeting at which a quorum shall be present or represented any business may be transacted which might have been transacted at the original meeting. If the adjournment is for more than 30 days, or if, after the adjournment, a new record date is fixed for the adjourned meeting, a notice of the adjourned meeting shall be given to each stockholder of record entitled to vote at the meeting.
Section 5. Conduct of Meetings. The Chair of the Board of Directors, or in the Chairs absence or at the Chairs direction, the Chair of the Corporations Corporate Governance and Nominating Committee, or in such Committee Chairs absence or at such Committee Chairs direction, another non-management director of the Corporation shall call all meetings of the stockholders to order and shall act as chair of such meeting. The Secretary of the Corporation or, in such officers absence, an Assistant Secretary shall act as secretary of the meeting. If neither the Secretary nor an Assistant Secretary of the Corporation is present, the chair of the meeting shall appoint a secretary of the meeting. Unless otherwise determined by the Board of Directors prior to the meeting, the chair of the meeting shall determine the order of business and shall have the authority in his or her discretion to regulate the conduct of any such meeting, including, without limitation, by imposing restrictions on the persons (other than stockholders of the Corporation or their duly appointed proxies) who may attend any such meeting, whether any stockholder or stockholders proxy may be excluded from any meeting of stockholders based upon any determination by the chair of the meeting, in his or her sole discretion, that any such person has unduly disrupted or is likely to disrupt the proceedings thereat, and the circumstances in which any person may make a statement or ask questions at any meeting of stockholders.
Section 6. Proxies. At all meetings of stockholders, any stockholder entitled to vote at such meeting shall be entitled to vote in person or by proxy, but no proxy shall be voted after three years from its date, unless such proxy provides for a longer period. Without limiting the manner in which a stockholder may authorize another person or persons to act for the stockholder as proxy pursuant to the General Corporation Law of the State of Delaware, the following shall constitute a valid means by which a stockholder may grant such authority: (a) a stockholder may execute a writing authorizing another person or persons to act for the stockholder as proxy, and execution of the writing may be accomplished by the stockholder or the stockholders authorized officer, director, employee or agent signing such writing or causing his or her signature to be affixed to such writing by any reasonable means including, but not limited to, by facsimile signature; or (b) a stockholder may authorize another person or persons to act for the stockholder as proxy by transmitting or authorizing the transmission of a telegram, cablegram, or other means of electronic transmission to the person who will be the holder of the proxy or to a proxy solicitation firm, proxy support service organization or like agent duly authorized by the person who will be the holder of the proxy to receive such transmission, provided that any such telegram, cablegram or other means of electronic transmission must either set forth or be submitted with information from which it can be determined that the telegram, cablegram or other electronic transmission was authorized by the stockholder. If it is determined that such telegrams, cablegrams or other electronic transmissions are valid, the judge or judges of stockholder votes or, if there are no such judges, such other persons making that determination shall specify the information upon which they relied.
Any copy, facsimile telecommunication or other reliable reproduction of the writing or transmission created pursuant to the preceding paragraph of this Section 6 may be substituted or used in lieu of the original writing or transmission for any and all purposes for which the original writing or transmission could be used, provided that such copy, facsimile telecommunication or other reproduction shall be a complete reproduction of the entire original writing or transmission.
Proxies shall be filed with the Secretary of the meeting prior to or at the commencement of the meeting to which they relate.
Section 7. Voting. When a quorum is present at any meeting, the vote of the holders of a majority in voting power of the stock present in person or represented by proxy and entitled to vote on the matter shall decide any question brought before such meeting, unless the question is one upon which by express provision of statute or of the Certificate of Incorporation or these By-Laws a different vote is required, in which case such express provision shall govern and control the decision of such question.
Section 8. Record Dates. In order that the Corporation may determine the stockholders (a) entitled to notice of or to vote at any meeting of stockholders or any adjournment thereof or (b) entitled to receive payment of any dividend or other distribution or allotment of any rights, or entitled to exercise any rights in respect of any change, conversion or exchange of stock or for the purpose of any other lawful action, the Board of Directors may fix a record date, which record date shall not precede the date upon which the resolution fixing the record date is adopted, and which record date (i) in the case of clause (a) above, shall not be more than sixty nor less than ten days before the date of such meeting and (ii) in the case of clause (b) above, shall not be more than sixty days prior to such action. If for any reason the Board of Directors shall not have fixed a record date for any such purpose, the record date for such purpose shall be determined as provided by law. Only those stockholders of record on the date so fixed or determined shall be entitled to any of the foregoing rights, notwithstanding the transfer of any such stock on the books of the Corporation after any such record date so fixed or determined.
CBRE - 2018 Proxy Statement | C-3 |
Section 9. Inspection of Stockholders List. The officer of the Corporation who has charge of the stock ledger of the Corporation shall prepare and make at least ten days before every meeting of stockholders, a complete list of the stockholders entitled to vote at the meeting, arranged in alphabetical order, and showing the address of each stockholder and the number of shares registered in the name of each stockholder. Such list shall be open to the examination of any stockholder, for any purpose germane to the meeting, during ordinary business hours, for a period of at least ten days prior to the meeting, either at a place within the city where the meeting is to be held, which place shall be specified in the notice of meeting, or, if not so specified, at the place where the meeting is to be held. The list shall also be produced at the time and kept at the place of the meeting during the whole time thereof, and may be inspected by any stockholder who is present.
Section 10. Judges of Stockholder Votes. The Board of Directors, in advance of all meetings of the stockholders, shall appoint one or more judges of stockholder votes, who may be stockholders or their proxies, but not directors of the Corporation or candidates for office. In the event that the Board of Directors fails to so appoint judges of stockholder votes or, in the event that one or more judges of stockholder votes previously designated by the Board of Directors fails to appear or act at the meeting of stockholders, the chair of the meeting may appoint one or more judges of stockholder votes to fill such vacancy or vacancies. Judges of stockholder votes appointed to act at any meeting of the stockholders, before entering upon the discharge of their duties, shall be sworn faithfully to execute the duties of judge of stockholder votes with strict impartiality and according to the best of their ability and the oath so taken shall be subscribed by them. Judges of stockholder votes shall, subject to the power of the chair of the meeting to open and close the polls, take charge of the polls, and, after the voting, shall make a certificate of the result of the vote taken.
Section 11. Notice and Information Requirements. (A) Annual Meetings of Stockholders. (1) Nominations of persons for election to the Board of Directors of the Corporation (other than directors to be nominated by any series of Preferred Stock, voting separately as a class, or pursuant to the Securityholders Agreement (as defined below)) and the proposal of other business to be considered by the stockholders may be made at an annual meeting of stockholders only (a) pursuant to the Corporations notice of meeting (or any supplement thereto), (b) by or at the direction of the Chair of the Board of Directors or the Board of Directors, (c) by any stockholder of the Corporation who is entitled to vote at the meeting, who complied with the notice procedures set forth in paragraphs (A)(2) and (A)(3) of this Article I, Section 11 and who was a stockholder of record at the time such notice is delivered to the Secretary of the Corporation or (d) by any stockholder of the Corporation who meets the requirements of and complies with the procedures set forth in Article 1, Section 12.
(2) For nominations or other business to be properly brought before an annual meeting by a stockholder pursuant to clause (c) of paragraph (A)(1) of this Article I, Section 11, the stockholder must have given timely notice thereof in writing to the Secretary of the Corporation, and any such proposed business other than nominations of persons for election to the Board of Directors must constitute a proper matter for stockholder action. To be timely, a stockholders notice shall be delivered to the Secretary at the principal executive offices of the Corporation not less than 90 days nor more than 120 days prior to the first anniversary date of the preceding years annual meeting; provided, however, that in the event that the date of the annual meeting is more than 30 days before, or more than 70 days after such anniversary date, notice by the stockholder to be timely must be so delivered not earlier than the close of business on the 120th day prior to such annual meeting and not later than the close of business on the later of the 90th day prior to such annual meeting or the tenth day following the day on which public announcement of the date of such meeting is first made. Such stockholders notice shall set forth (a) as to each person whom the stockholder proposes to nominate for election or re-election as a director, all information relating to such person that is required to be disclosed in solicitations of proxies for election of directors in an election contest, or is otherwise required, in each case pursuant to Regulation 14A under the Securities Exchange Act of 1934, as amended (the Exchange Act), including such persons written consent to being named in the proxy statement as a nominee and to serving as a director if elected; (b) as to any other business that the stockholder proposes to bring before the meeting, a brief description of the business desired to be brought before the meeting, the text of the proposal or business (including the text of any resolutions proposed for consideration and in the event that such business includes a proposal to amend these By-Laws, the language of the proposed amendment), the reasons for conducting such business at the meeting and any material interest in such business of such stockholder and the beneficial owner, if any, on whose behalf the proposal is made; (c) as to the stockholder giving the notice and the beneficial owner, if any, on whose behalf the nomination or proposal is made (i) the name and address of such stockholder, as they appear on the Corporations books and records, and of such beneficial owner, (ii) the class or series and number of shares of capital stock of the Corporation which are owned beneficially and of record by such stockholder and such beneficial owner, (iii) a representation that the stockholder is a holder of record of stock of the Corporation entitled to vote at such meeting and intends to appear in person or by proxy at the meeting to propose such business or nomination and (iv) a representation whether the stockholder or the beneficial owner, if any, intends or is part of a group which intends (x) to deliver a proxy statement and/or form of proxy to holders of at least the percentage of the Corporations outstanding capital stock required to approve or adopt the proposal or elect the nominee and/or (y) otherwise to solicit proxies from stockholders in support of such proposal or nomination; (d) a description of any agreement, arrangement or understanding with respect to the nomination or proposal and/or the voting of shares of any class or series of stock of the Corporation between or among the stockholder giving the notice, the beneficial owner, if any, on whose behalf the nomination or proposal is made, any of their respective affiliates or associates and/or any others acting in concert with any of the foregoing (collectively, proponent persons); and (e) a description of any
C-4 | CBRE - 2018 Proxy Statement |
agreement, arrangement or understanding (including without limitation any contract to purchase or sell, acquisition or grant of any option, right or warrant to purchase or sell, swap or other instrument) the intent or effect of which may be (i) to transfer to or from any proponent person, in whole or in part, any of the economic consequences of ownership of any security of the Corporation, (ii) to increase or decrease the voting power of any proponent person with respect to shares of any class or series of stock of the Corporation and/or (iii) to provide any proponent person, directly or indirectly, with the opportunity to profit or share in any profit derived from, or to otherwise benefit economically from, any increase or decrease in the value of any security of the Corporation. A stockholder providing notice of a proposed nomination for election to the Board of Directors or other business proposed to be brought before a meeting (whether given pursuant to this paragraph (A)(2) or paragraph (B) of this Article I, Section 11) shall update and supplement such notice from time to time to the extent necessary so that the information provided or required to be provided in such notice shall be true and correct as of the record date for the meeting and as of the date that is 15 days prior to the meeting or any adjournment or postponement thereof; such update and supplement shall be delivered in writing to the Secretary at the principal executive offices of the Corporation not later than 5 days after the record date for the meeting (in the case of any update and supplement required to be made as of the record date), and not later than 10 days prior to the date for the meeting or any adjournment or postponement thereof (in the case of any update and supplement required to be made as of 15 days prior to the meeting or any adjournment or postponement thereof). The Corporation may require any proposed nominee to furnish such other information as it may reasonably require to determine the eligibility of such proposed nominee to serve as a director of the Corporation.
(3) Notwithstanding anything in the second sentence of paragraph (A)(2) of this Article I, Section 11 to the contrary, in the event that the number of directors to be elected to the Board of Directors of the Corporation at an annual meeting is increased, and there is no public announcement naming all of the nominees for director or specifying the size of the increased Board of Directors made by the Corporation at least 100 days prior to the first anniversary of the preceding years annual meeting, a stockholders notice required by this Article I, Section 11 shall also be considered timely, but only with respect to nominees for any new positions created by such increase, if it shall be delivered to the Secretary at the principal executive offices of the Corporation not later than the close of business on the tenth day following the day on which such public announcement is first made by the Corporation.
(B) Special Meetings of Stockholders. Only such business shall be conducted at a special meeting of stockholders as shall have been brought before the meeting (1) in the case of a meeting called by the Chair of the Board of Directors, the Chief Executive Officer or the Board of Directors pursuant to a resolution approved by the Board of Directors, pursuant to the Corporations notice of meeting pursuant to Article I, Section 3 of these By-Laws, or (2) in the case of a Stockholder Requested Special Meeting upon the written request of holder(s) Owning the Requisite Percent, as shall have been proposed by such holder(s) pursuant to a notice setting forth the information required pursuant to paragraph (A)(2) of this Article I, Section 11, and such other purposes as shall be directed by the Board of Directors, in each case as set forth in the Corporations notice of meeting pursuant to Article I, Section 3 of these By-Laws. Nominations of persons for election to the Board of Directors may be made at a special meeting of stockholders at which directors are to be elected pursuant to the Corporations notice of meeting (i) by or at the direction of the Board of Directors (or stockholder(s) pursuant to Article Eighth of the Certificate of Incorporation) or (ii) provided that the Board of Directors (or stockholder(s) pursuant to Article Eighth of the Certificate of Incorporation) has determined that directors shall be elected at such meeting, by any stockholder of the Corporation who is entitled to vote at the meeting, who complies with the notice procedures set forth in this Article I, Section 11 and who is a stockholder of record at the time such notice is delivered to the Secretary. In the event the Corporation calls a special meeting of stockholders for the purpose of electing one or more directors to the Board of Directors, any such stockholder entitled to vote in such election of directors may nominate a person or persons (as the case may be) for election to such position(s) as specified in the Corporations notice of meeting, if the stockholders notice as required by paragraph (A)(2) of this Article I, Section 11 shall be delivered to the Secretary at the principal executive offices of the Corporation not earlier than the close of business on the 120th day prior to such special meeting and not later than the close of business on the later of the 90th day prior to such special meeting or the 10th day following the day on which public announcement is first made of the date of the special meeting and of the nominees proposed by the Board of Directors to be elected at such meeting.
(C) General. (1) Unless otherwise provided by the terms of any series of Preferred Stock, the Securityholders Agreement dated as of July 20, 2001, as amended from time to time (the Securityholders Agreement), among the Corporation, CBRE Services, Inc. (formerly known as CB Richard Ellis Services, Inc.) and the Corporations stockholders from time to time party thereto or any other agreement approved by the Corporations Board of Directors, only persons who are nominated in accordance with the procedures set forth in Article I, Sections 11 or 12 shall be eligible to serve as directors and only such business shall be conducted at a meeting of stockholders as shall have been brought before the meeting in accordance with the procedures set forth in this Article I, Section 11. Except as otherwise provided by law, the Certificate of Incorporation or these By-laws, the chair of the meeting shall have the power and duty to determine whether a nomination or any business proposed to be brought before the meeting was made in accordance with the procedures set forth in Article I, Sections 11 or 12 and, if any proposed nomination or business is not in compliance with Article I, Sections 11 or 12, to declare that such defective nomination shall be disregarded or that such proposed business shall not be transacted. Notwithstanding anything to the contrary in Article I, Sections 11 or 12, if the stockholder (or a qualified representative of the stockholder) does not appear at
CBRE - 2018 Proxy Statement | C-5 |
the annual or special meeting of stockholders of the Corporation to present a nomination or business, such nomination shall be disregarded and such proposed business shall not be transacted, notwithstanding that proxies in respect of such vote may have been received by the Corporation. For purposes of Article I, Sections 11 and 12, to be considered a qualified representative of the stockholder, a person must be a duly authorized officer, manager or partner of such stockholder or must be authorized by a writing executed by such stockholder or an electronic transmission delivered by such stockholder to act for such stockholder as proxy at the meeting of stockholders and such person must produce such writing or electronic transmission, or a reliable reproduction of the writing or electronic transmission, at the meeting of stockholders.
(2) For purposes of this Article I, Section 11, public announcement shall mean disclosure in a press release reported by the Dow Jones News Service, Associated Press or comparable national news service or in a document publicly filed by the Corporation with the Securities and Exchange Commission (the SEC) pursuant to Section 13, 14 or 15(d) of the Exchange Act.
(3) For purposes of these By-Laws, no adjournment or postponement nor notice of adjournment or postponement of any meeting shall be deemed to constitute a new notice of such meeting for purposes of Article I, Sections 11 and 12, and in order for any notification required to be delivered by a stockholder pursuant to Article I, Sections 11 and 12 to be timely, such notification must be delivered within the periods set forth above with respect to the originally scheduled meeting.
(4) Notwithstanding the foregoing provisions of this Article I, Section 11, a stockholder shall also comply with all applicable requirements of the Exchange Act and the rules and regulations thereunder with respect to the matters set forth in these By-Laws; provided, however, that any references in these By-Laws to the Exchange Act or the rules and regulations promulgated thereunder are not intended to and shall not limit any requirements applicable to nominations or proposals as to any other business to be considered pursuant to these By-Laws (including paragraphs (A)(1)(c) and (B) of this Article I, Section 11), and compliance with paragraphs (A)(1)(c) and (B) of this Article I, Section 11 shall be the exclusive means for a stockholder to make nominations or submit other business (other than as provided in Article I, Section 12). Nothing in these By-Laws shall be deemed to affect any rights of the holders of any series of Preferred Stock to elect directors pursuant to any applicable provisions of the Certificate of Incorporation (including any certificate of designations relating to any series of Preferred Stock).
Section 12. Proxy Access for Director Nominations. (A) Inclusion of Stockholder Nominees in the Corporations Proxy Materials. Notwithstanding anything to the contrary in these By-Laws, whenever the Board of Directors solicits proxies with respect to the election of Directors at an annual meeting of stockholders, subject to the provisions of this Article I, Section 12, the Corporation shall include in its proxy statement, form of proxy card and other applicable documents or filings with the SEC required in connection with the solicitation of proxies for the election of directors for such annual meeting (the Corporations proxy materials), in addition to any persons nominated for election by the Board of Directors or any committee thereof, the name of any person nominated for election to the Board of Directors pursuant to this Article I, Section 12 (the Stockholder Nominee) by an Eligible Stockholder (as defined below), and will include in its proxy statement for the annual meeting of stockholders the Required Information (as defined below), if the Eligible Stockholder satisfies the requirements of this Article I, Section 12 and expressly elects at the time of providing the notice required by this Article I, Section 12 (the Notice of Proxy Access Nomination) to have its Stockholder Nominee(s) included in the Corporations proxy materials pursuant to this Article I, Section 12. Nothing in this Article I, Section 12 shall limit the Corporations ability to solicit against, and include in its proxy materials its own statements relating to, any Stockholder Nominee, Eligible Stockholder, or group of stockholders acting collectively as an Eligible Stockholder.
(B) Qualification as an Eligible Stockholder. To qualify as an Eligible Stockholder, a stockholder or an eligible group of no more than 20 stockholders of the Corporation (counting the record holder and beneficial holder of the same shares of the Corporations stock as one stockholder for these purposes), must have owned (as defined below) the Nomination Required Ownership Percentage (as defined below) of the Corporations outstanding common stock entitled to vote generally in the election of directors of the Corporation (the Nomination Required Shares) continuously for the Minimum Holding Period (as defined below) as of both the date the Notice of Proxy Access Nomination is delivered to the Secretary of the Corporation in accordance with this Article I, Section 12 and the close of business on the record date for determining the stockholders entitled to vote at the annual meeting of stockholders of the Corporation, and thereafter must continue to own the Nomination Required Shares through the date of such annual meeting (and any postponement or adjournment thereof). For purposes of this Article I, Section 12, the Nomination Required Ownership Percentage is 3% and the Minimum Holding Period is three years.
In the event the Eligible Stockholder consists of a group of stockholders, any and all requirements and obligations for an individual Eligible Stockholder that are set forth in this Article I, Section 12, including the Minimum Holding Period, shall apply to each member of such group; provided, however, that the Nomination Required Ownership Percentage shall apply to the ownership of the group in the aggregate. No person may be a member of more than one group of persons constituting an Eligible Stockholder for purposes of nominations pursuant to this Article I, Section 12 with respect to any annual meeting of the stockholders of the Corporation (other than a record holder directed to act by more than one beneficial owner). If and to the extent a stockholder of record is acting on behalf of one or more beneficial owners, only the stock of the Corporation owned by
C-6 | CBRE - 2018 Proxy Statement |
such beneficial owner or owners, and not any other stock of the Corporation owned by any such stockholder of record, shall be counted for purposes of satisfying the Minimum Holding Period and Nomination Required Ownership Percentage. In addition, a group of any two or more funds that are under common management and investment control shall be treated as one stockholder of record or beneficial owner, as the case may be, for the purposes of forming a group to qualify as an Eligible Stockholder; provided that each fund otherwise meets the requirements set forth in this Article I, Section 12; and provided, further, that any such funds for which common stock of the Corporation is aggregated for the purpose of satisfying the Nomination Required Ownership Percentage provide documentation reasonably satisfactory to the Corporation that demonstrates that the funds meet the criteria set forth in this paragraph in the Notice of Proxy Access Nomination.
Whenever an Eligible Stockholder consists of a group of more than one stockholder, each provision in this Article I, Section 12 that requires the Eligible Stockholder to provide any information, written statements, representations, undertakings or agreements or to meet any other conditions shall be deemed to require each stockholder that is a member of such group to provide such information, statements, representations, undertakings or agreements and to meet such other conditions (which, if applicable, shall apply with respect to the portion of the Nomination Required Shares owned by such stockholder). When an Eligible Stockholder is comprised of a group of more than one stockholder, a violation of any provision of this Article I, Section 12 by any member of the group shall be deemed a violation by the entire group.
For purposes of this Article I, Section 12, an Eligible Stockholder shall be deemed to own only those outstanding shares of common stock of the Corporation as to which the stockholder possesses both: (1) the full voting and investment rights pertaining to the shares and (2) the full economic interest in (including the opportunity for profit from and risk of loss on) such shares; provided that the number of shares calculated in accordance with clauses (1) and (2) above shall not include any shares (a) sold by such stockholder or any of its affiliates in any transaction that has not been settled or closed, including any short sale, (b) borrowed by such stockholder or any of its affiliates for any purposes or purchased by such stockholder or any of its affiliates pursuant to an agreement to resell or (c) subject to any option, warrant, forward contract, swap, contract of sale, other derivative or similar instrument, agreement or arrangement entered into by such stockholder or any of its affiliates, whether any such instrument, agreement or arrangement is to be settled with shares or with cash based on the notional amount or value of shares of outstanding common stock of the Corporation, in any such case which instrument, agreement or arrangement has, or is intended to have, or if exercised by either party would have, the purpose or effect of (i) reducing in any manner, to any extent or at any time in the future, such stockholders or its affiliates full right to vote or direct the voting of any such shares and/or (ii) hedging, offsetting or altering to any degree any gain or loss realized or realizable from maintaining the full economic ownership of such shares by such stockholder or its affiliates. An Eligible Stockholder shall own shares of common stock held in the name of a nominee or other intermediary so long as the stockholder retains the right to instruct how the shares are voted with respect to the election of directors and possesses the full economic interest in the shares. A stockholders ownership of shares of common stock shall be deemed to continue during any period in which (I) the stockholder has loaned such shares, provided that the stockholder has the power to recall such loaned shares on five business days notice and provides a representation to the Corporation that it will promptly recall such loaned shares upon being notified that any of its Stockholder Nominees will be included in the Corporations proxy materials, or (II) the stockholder has delegated any voting power by means of a proxy, power of attorney or other instrument or arrangement which is revocable at any time by the stockholder. The terms owned, owning and other variations of the word own in this Article I, Section 12 shall have correlative meanings. Whether outstanding shares of the common stock of the Corporation are owned for these purposes shall be determined by the Board of Directors or any committee thereof, in each case, in its sole discretion, which determination shall be conclusive and binding on the Corporation, its stockholders and beneficial owners and all other parties. For purposes of this Article I, Section 12, the term affiliate or affiliates shall have the meaning ascribed thereto under rules and regulations promulgated under the Exchange Act.
(C) Required Information. For purposes of this Article I, Section 12, the Required Information that the Corporation will include in its proxy statement is (1) the information provided to the Secretary of the Corporation concerning the Stockholder Nominee and the Eligible Stockholder that is required to be disclosed in the Corporations proxy statement by applicable requirements of the Exchange Act and the rules and regulations promulgated thereunder, and (2) if the Eligible Stockholder so elects, a written statement of the Eligible Stockholder, not to exceed 500 words, in support of the candidacy of the Stockholder Nominee(s), which must be delivered to the Secretary of the Corporation at the time the Notice of Proxy Access Nomination required by this Article I, Section 12 is delivered (the Statement). Notwithstanding anything to the contrary contained in this Article I, Section 12, the Corporation may omit from its proxy statement any information or the Statement (or portion thereof) that it, in good faith, believes is untrue in any material respect (or omits to state a material fact necessary in order to make the statements made, in light of the circumstances under which they are made, not misleading) or would violate any applicable law, rule, regulation or listing standard. Nothing in this Article I, Section 12 shall limit the Corporations ability to solicit against and include in the Corporations proxy materials its own statements or other information relating to the Eligible Stockholder or any Stockholder Nominee.
(D) Maximum Number of Stockholder Nominees. The maximum number of Stockholder Nominees nominated by all Eligible Stockholders (including any Stockholder Nominee that was submitted by an Eligible Stockholder for inclusion in the Corporations proxy materials pursuant to this Article I, Section 12 but was subsequently withdrawn, disregarded pursuant to
CBRE - 2018 Proxy Statement | C-7 |
this Article I, Section 12 or declared invalid or ineligible) that will be included in the Corporations proxy materials with respect to an annual meeting of stockholders shall not exceed the greater of (1) 20% of the total number of directors in office (rounded down to the nearest whole number) as of the last day on which a Notice of Proxy Access Nomination may be timely delivered pursuant to and in accordance with this Article I, Section 12 (the Final Proxy Access Nomination Date) or (2) two (the Maximum Number). In the event that one or more vacancies for any reason occurs on the Board of Directors after the Final Proxy Access Nomination Date but before the date of the annual meeting of stockholders and the Board of Directors resolves to reduce the size of the Board of Directors in connection therewith, the Maximum Number of Stockholder Nominees eligible for inclusion in the Corporations proxy materials pursuant to this Article I, Section 12 shall be calculated based on the number of directors in office as so reduced.
The Maximum Number shall be reduced, but not below zero, by the sum of:
(a) the number of individuals nominated by an Eligible Stockholder for inclusion in the Corporations proxy materials pursuant to this Article I, Section 12 whom the Board of Directors decides to nominate as a nominee of the Board of Directors;
(b) the number of individuals that the Board of Directors decides to nominate for re-election who were Stockholder Nominees at one of the previous three annual meetings of stockholders; and
(c) the number of Stockholder Nominees whose nomination was subsequently withdrawn or otherwise deemed invalid pursuant to this Article 1, Sections 11(C)(1), 12(H) or 12(I)(1).
Any Eligible Stockholder submitting more than one Stockholder Nominee for inclusion in the Corporations proxy materials pursuant to this Article I, Section 12 shall rank such Stockholder Nominees in its Notice of Proxy Access Nomination based on the order that the Eligible Stockholder desires such Stockholder Nominees to be selected for inclusion in the Corporations proxy materials in the event that the total number of Stockholder Nominees submitted by Eligible Stockholders pursuant to this Article I, Section 12 exceeds the Maximum Number. In the event that the number of Stockholder Nominees submitted by Eligible Stockholders pursuant to this Article I, Section 12 exceeds the Maximum Number, the highest ranking Stockholder Nominee who meets the requirements of this Article I, Section 12 from each Eligible Stockholder will be selected for inclusion in the Corporations proxy materials until the Maximum Number is reached, beginning with the Eligible Stockholder or group of Eligible Stockholders with the largest number of shares of the Corporations outstanding common stock each Eligible Stockholder disclosed as owned in its respective Notice of Proxy Access Nomination submitted to the Corporation and preceding through each Eligible Stockholder or group Eligible Stockholders in descending order of ownership. If the Maximum Number is not reached after the highest ranking Stockholder Nominee who meets the requirements of this Article I, Section 12 from each Eligible Stockholder has been selected, this process will continue as many times as necessary, following the same order each time, until the Maximum Number is reached or there are no remaining Stockholder Nominees.
(E) Timing of Notice. To be eligible to have its nominee included in the Corporations proxy materials pursuant to this Article I, Section 12, an Eligible Stockholder shall have timely delivered, in proper form, a Notice of Proxy Access Nomination to the Secretary. To be timely, the Notice of Proxy Access Nomination shall be delivered to the Secretary at the principal executive offices of the Corporation in proper form not less than 90 days nor more than 120 days prior to the first anniversary date of the preceding years annual meeting; provided, however, that in the event that the date of the annual meeting is more than 30 days before, or more than 70 days after such anniversary date, notice by an Eligible Stockholder to be timely must be so delivered not earlier than the close of business on the 120th day prior to such annual meeting and not later than the close of business on the later of the 90th day prior to such annual meeting or the tenth day following the day on which public announcement of the date of such meeting is first made.
(F) Form and Content of Notice. To be in proper form for purposes of this Article I, Section 12, the Notice of Proxy Access Nomination to the Secretary must be in writing and shall include the following information:
(1) an express request that each Stockholder Nominee be included in the Corporations proxy materials pursuant to this Article I, Section 12;
(2) one or more written statements from the record holder of the Nomination Required Shares (and from each intermediary through which the Nomination Required Shares are or have been held during the Minimum Holding Period) verifying that, as of a date within seven calendar days prior to the date the Notice of Proxy Access Nomination is delivered to the Secretary of the Corporation, the Eligible Stockholder owns, and has owned continuously for the Minimum Holding Period, the Nomination Required Shares, and the Eligible Stockholders agreement to provide, within five business days after the record date for the annual meeting of stockholders, written statements from the record holder and intermediaries verifying the Eligible Stockholders continuous ownership of the Nomination Required Shares through the record date, together with a written statement by the Eligible Stockholder that such Stockholder will continue to own the Nomination Required Shares through the date of such annual meeting (and any postponement or adjournment thereof);
(3) with respect to each Eligible Stockholder or member of a group comprising an Eligible Stockholder, (a) the number of shares of the Corporations capital stock that such Eligible Stockholder is deemed to own for the purposes of this Article I, Section 12, (b) the class or series and form of ownership for such shares and (c) the number of shares of the Corporations capital stock (i) sold by such stockholder or any of its affiliates in any transaction that has not been settled or closed, including
C-8 | CBRE - 2018 Proxy Statement |
any short sale, (ii) borrowed by such stockholder or any of its affiliates for any purposes or purchased by such stockholder or any of its affiliates pursuant to an agreement to resell, (iii) subject to any option, warrant, forward contract, swap, contract of sale, other derivative or similar instrument, agreement or arrangement entered into by such stockholder or any of its affiliates, whether any such instrument, agreement or arrangement is to be settled with shares or with cash based on the notional amount or value of shares of outstanding common stock of the Corporation, in any such case which instrument, agreement or arrangement has, or is intended to have, or if exercised by either party would have, the purpose or effect of (I) reducing in any manner, to any extent or at any time in the future, such stockholders or its affiliates full right to vote or direct the voting of any such shares and/or (II) hedging, offsetting or altering to any degree any gain or loss realized or realizable from maintaining the full economic ownership of such shares by such stockholder or its affiliates, (iv) over which such stockholder does not retain the right to instruct how such shares are voted with respect to the election of directors, (v) over which such stockholder does not possesses the full economic interest, (vi) subject to a loan that does not permit such stockholder to recall such loaned shares on three business days notice, or (vii) for which such stockholder has delegated any voting power by means of a proxy, power of attorney or other instrument or arrangement which is not revocable at any time by such stockholder.
(4) a copy of any Schedule 14N that has been or concurrently is filed with the SEC as required by Rule 14a-18 under the Exchange Act, as such rule may be amended;
(5) the other information, representations and agreements that are the same as those that would be required to be set forth in a stockholders notice of nomination pursuant to Article I, Section 11(A)(2);
(6) the consent of each Stockholder Nominee to be named in the Corporations proxy materials as a nominee, to serve as a Director if elected, and to the public disclosure of the information provided pursuant to this Article I, Section 12;
(7) a representation that the Eligible Stockholder (including each group member, in the case of nomination by a group of stockholders):
(a) acquired the Nomination Required Shares in the ordinary course of business and not with the intent to change or influence control of the Corporation, and that neither the Eligible Stockholder nor any Stockholder Nominee being nominated thereby presently has such intent;
(b) has not nominated and will not nominate for election to the Board of Directors at the annual meeting of stockholders any person other than its Stockholder Nominee(s) being nominated pursuant to this Article I, Section 12;
(c) has not engaged and will not engage in, with respect to the applicable annual meeting, and has not and will not be a participant in, another persons or groups solicitation within the meaning of Rule 14a-1(l) under the Exchange Act in support of the election of any individual as a Director at the annual meeting of stockholders, other than its Stockholder Nominee(s) or a nominee of the Board of Directors;
(d) will not distribute to any stockholder of the Corporation any form of proxy for the annual meeting of stockholders other than the form distributed by the Corporation;
(e) has provided and will provide facts, statements and other information in all communications with the Corporation and its stockholders and beneficial owners, including without limitation the Notice of Proxy Access Nomination and the Statement, that are and will be true and correct in all material respects and do not and will not omit to state a material fact necessary in order to make the statements made in light of the circumstances under which they were made, not misleading; and
(f) consents to the public disclosure by the Corporation of the information provided pursuant to this Article I, Section 12;
(8) an executed agreement, in a form deemed satisfactory by the Board of Directors, pursuant to which the Eligible Stockholder agrees to:
(a) assume all liability stemming from any legal or regulatory violation arising out of communications with the stockholders of the Corporation by the Eligible Stockholder, its affiliates and associates or their respective agents or representatives, either before or after providing a Notice of Proxy Access Nomination pursuant to this Article I, Section 12, or out of the information that the Eligible Stockholder or its Stockholder Nominee(s) provided to the Corporation pursuant to this Article I, Section 12 or otherwise in connection with the inclusion of such Stockholder Nominee(s) in the Corporations proxy materials pursuant to this Article I, Section 12;
(b) indemnify and hold harmless the Corporation and each of its directors, officers, employees, agents and affiliates individually against any liability, loss or damages in connection with any threatened or pending action, suit or proceeding, whether legal, administrative or investigative arising out of or relating to any nomination submitted by the Eligible Stockholder pursuant to this Article I, Section 12;
(c) comply with all applicable laws and regulations with respect to any solicitation, or applicable to the filing and use, if any, of soliciting material, in connection with the annual meeting of stockholders; and
CBRE - 2018 Proxy Statement | C-9 |
(d) file with the SEC any solicitation or other communication with the Corporations stockholders relating to the meeting at which the Stockholder Nominee will be nominated, regardless of whether any such filing is required under Regulation 14A of the Exchange Act or whether any exemption from filing is available thereunder;
(9) in the case of a nomination by a group of stockholders that together is an Eligible Stockholder, the designation by all group members of one group member that is authorized to act on behalf of all such members with respect to the nomination and matters related thereto, including withdrawal of the nomination; and
(10) a letter of resignation signed by each Stockholder Nominee, which letter shall specify that such Stockholder Nominees resignation from the Board of Directors is irrevocable and that it shall become effective upon a determination by the Board of Directors or any committee thereof that (a) any of the information provided to the Corporation by the Eligible Stockholder or any member of a group of stockholders acting collectively as an Eligible Stockholder (including any beneficial owner on whose behalf the nomination was made) or the Stockholder Nominee in respect of the nomination of such Stockholder Nominee pursuant to this Article I, Section 12 is or was untrue in any material respect (or omitted to state a material fact necessary in order to make the statements made, in light of the circumstances under which they were made, not misleading) or (b) the Eligible Stockholder or any member of a group of stockholders acting collectively as an Eligible Stockholder (including any beneficial owner on whose behalf the nomination was made) or the Stockholder Nominee shall have breached any of their respective representations, obligations or agreements under this Article I, Section 12.
The Corporation may also require each Eligible Stockholder and Stockholder Nominee to furnish such additional information as may reasonably be necessary to permit the Board of Directors to determine if each Stockholder Nominee is independent under the listing standards of the principal U.S. exchange upon which the common stock of the Corporation is listed, any applicable rules of the SEC and any publicly disclosed standards used by the Board of Directors in determining and disclosing the independence of the Corporations Directors or as may reasonably be required by the Corporation to determine that the Eligible Stockholder meets the criteria for qualification as an Eligible Stockholder.
(G) Breach and Duty to Update. In the event that an Eligible Stockholder, or any member of a group acting collectively as an Eligible Stockholder, shall have breached any of their respective representations, obligations or agreements with the Corporation, or any information included in the Statement or the Notice of Proxy Access Nomination or any other communications by such Eligible Stockholder or member of a group acting collectively as an Eligible Stockholder (including any beneficial owner on whose behalf the nomination is made) with the Corporation or its stockholders and beneficial owners ceases to be true and correct in all material respects (or omits a material fact necessary to make the statements made, in light of the circumstances under which they were made, not misleading), each Eligible Stockholder or any member of a group acting collectively as an Eligible Stockholder (including any beneficial owner on whose behalf the nomination is made), as the case may be, shall promptly (and in any event within 24 hours of discovering such breach or that such information has ceased to be true and correct in all material respects (or omits a material fact necessary to make the statements made, in light of the circumstances under which they were made, not misleading) notify the Secretary of the Corporation of any such breach, inaccuracy or omission in such previously provided information and shall provide the information that is required to correct any such defect, if applicable.
(H) Disqualification of Stockholder Nominees. The Corporation shall not be required to include, pursuant to this Article I, Section 12, a Stockholder Nominee in the Corporations proxy materials for any meeting of stockholders, or, if the proxy statement already has been filed, to allow the nomination of a Stockholder Nominee, notwithstanding that proxies in respect of such vote may have been received by the Corporation:
(1) for which the Secretary of the Corporation receives a notice that a stockholder has nominated a person for election to the Board of Directors pursuant to the advance notice requirements for stockholder nominees for Director set forth in this Article I, Section 11;
(2) if the Eligible Stockholder who has nominated such Stockholder Nominee has engaged in or is currently engaged in, or has been or is a participant in, another persons solicitation within the meaning of Rule 14a-1(l) under the Exchange Act in support of the election of any individual as a Director at the annual meeting of stockholders other than its Stockholder Nominee(s) or a nominee of the Board of Directors;
(3) if such Stockholder Nominee is not independent under the listing standards of the principal U.S. exchange upon which the common stock of the Corporation is listed, any applicable rules of the SEC and any publicly disclosed standards used by the Board of Directors in determining and disclosing independence of the Corporations directors, including those applicable to a directors service on any of the committees of the Board of Directors, in each case as determined by the Board of Directors in its sole discretion;
(4) if the election of such Stockholder Nominee as a member of the Board of Directors would cause the Corporation to be in violation of these By-Laws, the Certificate of Incorporation, the listing standards of the principal U.S. exchange upon which the common stock of the Corporation is listed, or any applicable state or federal law, rule or regulation or standards of the Corporation applicable to directors, in each case as determined by the Board of Directors in its sole discretion;
C-10 | CBRE - 2018 Proxy Statement |
(5) if such Stockholder Nominee is or has been, within the past three years, an officer or director of a competitor, as defined in Section 8 of the Clayton Antitrust Act of 1914, as amended, of the Corporation or its subsidiaries, or is a representative of an entity that has or has had a representative functioning as such an officer or director during such period;
(6) if such Stockholder Nominee is a named subject of a pending criminal proceeding (excluding traffic violations and other minor offenses) or has been convicted in such a criminal proceeding within the past ten years;
(7) if such Stockholder Nominee is subject to any order of the type specified in Rule 506(d) of Regulation D promulgated under the Securities Act of 1933, as amended;
(8) if such Stockholder Nominee or the applicable Eligible Stockholder shall have provided information to the Corporation in respect to such nomination that was untrue in any material respect or omitted to state a material fact necessary in order to make the statement made, in light of the circumstances under which they were made, not misleading, as determined by the Board of Directors or any committee thereof, in each case, in its sole discretion;
(9) if the Eligible Stockholder who has nominated such Stockholder Nominee or such Stockholder Nominee otherwise contravenes any of the agreements or representations made by such Eligible Stockholder or Stockholder Nominee or fails to comply with its obligations pursuant to this Article I, Section 12; or
(10) whose business or personal interests place such Stockholder Nominee in a conflict of interest with the Corporation or any of its subsidiaries, as determined by the Board of Directors in its sole discretion.
For the purpose of this Article I, Section 12(H), clauses (2) through (10) will result in the exclusion from the Corporations proxy materials pursuant to this Article I, Section 12 of the specific Stockholder Nominee(s) to whom the ineligibility applies, or, if the Corporations proxy statement already has been filed, the ineligibility of the Stockholder Nominee(s) and the inability of the Eligible Stockholder that nominated any such Stockholder Nominee to substitute another Stockholder Nominee therefor; however, clause (1) will result in the exclusion from the proxy materials pursuant to this Article I, Section 12 of all Stockholder Nominees from such Eligible Stockholder for the applicable annual meeting, or, if the Corporations proxy statement already has been filed, the ineligibility of all Stockholder Nominees.
(I) General. Notwithstanding the foregoing provisions of this Article I, Section 12, unless otherwise required by law:
(1) if the Stockholder Nominee(s) and/or the applicable Eligible Stockholder shall have breached its or their obligations under this Article I, Section 12, as determined by the Board of Directors or the chairperson of the meeting of stockholders, in each case, in its, his or her sole discretion, such nomination shall, without further action, be disregarded, notwithstanding that proxies in respect of such vote may have been received by the Corporation;
(2) the Corporation may omit from its proxy materials any information, including all or any portion of the Nomination Statement, if the Board of Directors determines that the disclosure of such information would violate any applicable law or regulation or that such information is not true and correct in all material respects or omits to state a material fact necessary in order to make the statements made, in light of the circumstances under which they were made, not misleading; and
(3) the Board of Directors (and any other person or body authorized by the Board of Directors) shall have the power and authority to interpret this Article I, Section 12 and to make any and all determinations necessary or advisable to apply this Article I, Section 12 to any persons, facts or circumstances. Any such interpretation or determination adopted in good faith by the Board of Directors (or any other person or body authorized by the Board of Directors) shall be conclusive and binding on all persons, including the Corporation and its stockholders of record and beneficial owners).
(J) Exclusive Method. This Article I, Section 12 shall be the exclusive method for stockholders to include nominees for election to the Board of Directors in the Corporations proxy materials.
ARTICLE II.
BOARD OF DIRECTORS
Section 1. Number, Election, Quorum. The Board of Directors of the Corporation shall consist of such number of directors, not less than three, as shall from time to time be fixed exclusively by resolution of the Board of Directors. The Board shall not nominate for election more than one member of the Corporations management. A nominee for director shall (except as hereinafter provided for the filling of vacancies and newly created directorships) be elected to the Board of Directors if the votes cast for such nominees election exceed the votes cast as against such nominees election; provided, however, that directors shall be elected by a plurality of the votes cast at any meeting of stockholders for which (i) the Secretary receives a notice (which purports to be in compliance with the notice procedures set forth in Article I, Section 11 of these By-Laws, irrespective of whether the Board of Directors thereafter determines that such notice is not in compliance with such procedures) that a stockholder has nominated a person for election to the Board of Directors and (ii) such nomination has not been withdrawn by such stockholder on or before the 14th day before the Corporation first mails to the stockholders its notice of meeting for such meeting. A majority of the total number of directors then in office (but not less than one-third of the number
CBRE - 2018 Proxy Statement | C-11 |
of directors constituting the entire Board of Directors) shall constitute a quorum for the transaction of business and, except as otherwise provided by law or by the Certificate of Incorporation, the act of a majority of the directors present at any meeting at which there is a quorum shall be the act of the Board of Directors. Directors need not be stockholders.
Section 2. Term Limits. The Board of Directors will not nominate for re-election any non-management director if that director has completed 12 years of service as an Independent Member (as defined below) of the Board of Directors on or prior to the date of election to which such nomination relates. The restriction in the immediately preceding sentence shall not apply until December 17, 2020 for any person who is a director as of December 17, 2015. For purposes of this Section 2 and the immediately following Section 3, Independent Member means a member of the Board of Directors that meets the criteria for independence required by the New York Stock Exchange or such other exchange upon which the Corporations securities are publicly traded from time to time.
Section 3. Chair of the Board of Directors. The Board of Directors, after each annual meeting of the stockholders, shall elect a Chair of the Board of Directors who shall be an Independent Member (as defined above) of the Board of Directors. The Chair of the Board of Directors shall hold office until his or her successor is elected by the Board of Directors, or until his or her earlier resignation or removal. The Chair of the Board of Directors may be removed as Chair at any time with or without cause by the majority vote of the Board of Directors. The Board of Directors shall fill any vacancy in the position of Chair of the Board of Directors at such time and in such manner as the Board of Directors shall determine.
Section 4. Newly-Created Directorships and Vacancies. Unless otherwise required by law and subject to Section 6 of this Article II, newly created directorships in the Board of Directors that result from an increase in the number of directors and any vacancy occurring in the Board of Directors may be filled only by a majority of the directors then in office, although less than a quorum, or by a sole remaining director; and the directors so chosen shall hold office for a term as set forth in the Certificate of Incorporation. If any applicable provision of the General Corporation Law of the State of Delaware expressly confers power on stockholders to fill such a directorship at a special meeting of stockholders, such a directorship may be filled at such a meeting.
Section 5. Meetings. Meetings of the Board of Directors shall be held at such place within or without the State of Delaware as may from time to time be fixed by resolution of the Board of Directors or as may be specified in the notice of any meeting. Regular meetings of the Board of Directors shall be held at such times as may from time to time be fixed by resolution of the Board of Directors and special meetings may be held at any time upon the call of the Chair of the Board of Directors or the Chief Executive Officer, by oral, or written notice including, telegraph, telex or transmission of a telecopy, e-mail or other means of transmission, duly served on or sent or mailed to each director to such directors address or telecopy number as shown on the books of the Corporation not less than one day before the meeting. The notice of any meeting need not specify the purposes thereof. A meeting of the Board of Directors may be held without notice immediately after the annual meeting of stockholders at the same place at which such meeting is held. Notice need not be given of regular meetings of the Board of Directors held at times fixed by resolution of the Board of Directors. Notice of any meeting need not be given to any director who shall attend such meeting in person (except when the director attends a meeting for the express purpose of objecting at the beginning of the meeting to the transaction of any business because the meeting is not lawfully called or convened), or who shall waive notice thereof, before or after such meeting, in writing.
Section 6. Election of Directors by Holders of Preferred Stock. Notwithstanding the foregoing, whenever the holders of any one or more series of Preferred Stock issued by the Corporation shall have the right, voting separately by series, to elect directors at an annual or special meeting of stockholders, the election, term of office, removal, and other features of such directorships shall be governed by the terms of the Certificate of Incorporation (including any certificate of designations relating to any series of Preferred Stock) applicable thereto. The number of directors that may be elected by the holders of any such series of Preferred Stock shall be in addition to the number fixed by or pursuant to these By-Laws. Except as otherwise expressly provided in the terms of such series, the number of directors that may be so elected by the holders of any such series of stock shall be elected for terms expiring at the next annual meeting of stockholders, and vacancies among directors so elected by the separate vote of the holders of any such series of Preferred Stock shall be filled by the affirmative vote of a majority of the remaining directors elected by such series, or, if there are no such remaining directors, by the holders of such series in the same manner in which such series initially elected a director.
Section 7. Election of Directors by Multiples Classes or Series of Stock. If at any meeting for the election of directors, the Corporation has outstanding more than one class of stock, and one or more such classes or series thereof are entitled to vote separately as a class, and there shall be a quorum of only one such class or series of stock, that class or series of stock shall be entitled to elect its quota of directors notwithstanding absence of a quorum of the other class or series of stock.
Section 8. Executive Committee. The Board of Directors may designate three or more directors to constitute an executive committee to serve at the pleasure of the Board of Directors, one of whom shall be designated chair of such committee. The members of such committee shall be comprised of such members of the Board of Directors as the Board of Directors shall from time to time establish. Any vacancy occurring in the committee shall be filled by the Board of Directors. Regular meetings of the committee shall be held at such times and on such notice and at such places as it may from time to time determine. The committee shall act, advise with and aid the officers of the Corporation in all matters concerning its interest and the
C-12 | CBRE - 2018 Proxy Statement |
management of its business, and shall generally perform such duties and exercise such powers as may from time to time be delegated to it by the Board of Directors. The committee shall have power to authorize the seal of the Corporation to be affixed to all papers which are required by the General Corporation Law of the State of Delaware to have the seal affixed thereto.
The executive committee shall keep regular minutes of its transactions and shall cause them to be recorded in a book kept in the office of the Corporation designated for that purpose, and shall report the same to the Board of Directors at their regular meeting. The committee shall make and adopt its own rules for the government thereof and shall elect its own officers.
Section 9. Other Committees. The Board of Directors may from time to time establish such other committees to serve at the pleasure of the Board of Directors (including, without limitation, an audit committee (or audit and finance committee), a compensation committee and a corporate governance and nominating committee) which shall be comprised of such members of the Board of Directors and have such duties as the Board of Directors shall from time to time establish. Any director may belong to any number of committees of the Board of Directors. The Board of Directors may also establish such other committees with such members (whether or not directors) and such duties as the Board of Directors may from time to time determine.
Section 10. Action by Unanimous Written Consent in Lieu of a Meeting. Unless otherwise restricted by the Certificate of Incorporation or these By-Laws, any action required or permitted to be taken at any meeting of the Board of Directors or of any committee thereof may be taken without a meeting if all members of the Board of Directors or committee, as the case may be, consent thereto in writing, and the writing or writings are filed with the minutes of proceedings of the Board of Directors.
Section 11. Remote Participation. The members of the Board of Directors or any committee thereof may participate in a meeting of such Board of Directors or committee, as the case may be, by means of conference telephone or similar communications equipment by means of which all persons participating in the meeting can hear each other, and participation in a meeting pursuant to this subsection shall constitute presence in person at such a meeting.
Section 12. Compensation. The Board of Directors may establish policies for the compensation of directors and for the reimbursement of the expenses of directors, in each case, in connection with services provided by directors to the Corporation.
ARTICLE III.
OFFICERS
Section 1. Election. The Board of Directors, after each annual meeting of the stockholders, shall elect officers of the Corporation, including a Chief Executive Officer, a President and a Secretary. The Board of Directors may also from time to time elect such other officers (including one or more Vice Presidents, a Treasurer, one or more Assistant Vice Presidents, one or more Assistant Secretaries, one or more Assistant Treasurers or one or more Vice Chairs of the Board) as it may deem proper or may delegate to any elected officer of the Corporation the power to appoint and remove any such other officers and to prescribe their respective terms of office, authorities and duties. Any Vice President may be designated Executive, Senior or Corporate, or may be given such other designation or combination of designations as the Board of Directors may determine. Any two or more offices may be held by the same person.
Section 2. Terms. All officers of the Corporation elected by the Board of Directors shall hold office for such term as may be determined by the Board of Directors or until their respective successors are chosen and qualified. Any officer may be removed from office at any time either with or without cause by the affirmative vote of a majority of the members of the Board of Directors then in office, or, in the case of appointed officers, by any elected officer upon whom such power of removal shall have been conferred by the Board of Directors.
Section 3. Powers and Duties. Each of the officers of the Corporation elected by the Board of Directors or appointed by an officer in accordance with these By-laws shall have the powers and duties prescribed by law, by these By-Laws or by the Board of Directors and, in the case of appointed officers, the powers and duties prescribed by the appointing officer, and, unless otherwise prescribed by these By-Laws or by the Board of Directors or such appointing officer, shall have such further powers and duties as ordinarily pertain to that office.
Section 4. Delegation. Unless otherwise provided in these By-Laws, in the absence or disability of any officer of the Corporation, the Board of Directors may, during such period, delegate such officers powers and duties to any other officer or to any director and the person to whom such powers and duties are delegated shall, for the time being, hold such office.
ARTICLE IV.
CERTIFICATES OF STOCK
Section 1. Form. The shares of stock of the Corporation shall be represented by certificates, provided that the Board of Directors may provide by resolution or resolutions that some or all of any or all classes or series of the Corporations stock shall be uncertificated shares. Any such resolution shall not apply to shares represented by a certificate until such certificate is
CBRE - 2018 Proxy Statement | C-13 |
surrendered to the Corporation. Notwithstanding the adoption of such a resolution by the Board of Directors, every holder of stock represented by certificates and upon request every holder of uncertificated shares shall be entitled to have a certificate signed by, or in the name of the Corporation by the Chair of the Board of Directors, or the President or a Vice President, and by the Treasurer or the Secretary of the Corporation, or as otherwise permitted by law, representing the number of shares registered in certificate form. Any or all the signatures on the certificate may be a facsimile.
Section 2. Transfers. Transfers of stock shall be made on the books of the Corporation by the holder of the shares in person or by such holders attorney upon surrender and cancellation of certificates for a like number of shares, or as otherwise provided by law with respect to uncertificated shares.
Section 3. Loss, Stolen or Destroyed Certificates. No certificate for shares of stock in the Corporation shall be issued in place of any certificate alleged to have been lost, stolen or destroyed, except upon production of such evidence of such loss, theft or destruction and upon delivery to the Corporation of a bond of indemnity in such amount, upon such terms and secured by such surety, as the Board of Directors in its discretion may require.
ARTICLE V.
CORPORATE BOOKS
The books of the Corporation may be kept outside of the State of Delaware at such place or places as the Board of Directors may from time to time determine.
ARTICLE VI.
CHECKS, NOTES, PROXIES, ETC.
All checks and drafts on the Corporations bank accounts and all bills of exchange and promissory notes, and all acceptances, obligations and other instruments for the payment of money, shall be signed by such officer or officers or agent or agents as shall be authorized from time to time by the Board of Directors. Proxies to vote and consents with respect to securities of other corporations owned by or standing in the name of the Corporation may be executed and delivered from time to time on behalf of the Corporation by the Chair of the Board of Directors, the Chief Executive Officer or President, or by such officers as the Board of Directors may from time to time determine.
ARTICLE VII.
FISCAL YEAR
The fiscal year of the Corporation shall begin on the first day of January in each year and shall end on the thirty-first day of December following.
ARTICLE VIII.
CORPORATE SEAL
The corporate seal shall have inscribed thereon the name of the Corporation. In lieu of the corporate seal, when so authorized by the Board of Directors or a duly empowered committee thereof, a facsimile thereof may be impressed or affixed or reproduced.
ARTICLE IX.
EXCLUSIVE FORUM
Unless the Corporation consents in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware shall, to the fullest extent permitted by applicable law, be the sole and exclusive forum for (i) any derivative action or proceeding brought on behalf of the Corporation, (ii) any action asserting a claim of breach of a fiduciary duty owed by any director, officer, other employee or stockholder of the Corporation to the Corporation or the Corporations stockholders, (iii) any action arising pursuant to any provision of the General Corporation Law of the State of Delaware or as to which the General Corporation Law of the State of Delaware confers jurisdiction on the Court of Chancery of the State of Delaware, or (iv) any action asserting a claim governed by the internal affairs doctrine. Any person or entity purchasing or otherwise acquiring any interest in shares of capital stock of the Corporation shall be deemed to have notice of and consented to the provisions of this Article IX.
C-14 | CBRE - 2018 Proxy Statement |
ARTICLE X.
AMENDMENTS
These By-Laws may be amended, added to, rescinded or repealed at any meeting of the Board of Directors or of the stockholders, provided notice of the proposed change was given in the notice of the meeting of the stockholders or, in the case of a meeting of the Board of Directors, in a notice given not less than two days prior to the meeting.
***
CBRE - 2018 Proxy Statement | C-15 |
CBRE GROUP, INC.
C/O BROADRIDGE
P.O. BOX 1342
BRENTWOOD, NY 11717
VOTE BY INTERNET - www.proxyvote.com
Use the internet to transmit your voting instructions and
for electronic delivery of information up until 8:59 p.m. (Pacific Time) on May 17, 2018, unless you are voting shares held in CBRE Group, Inc.s 401(k) plan, in which case the deadline is 8:59 p.m. (Pacific Time) on May 15, 2018 (the
401(k) cut-off time). Have your proxy card in hand when you access the website and follow the instructions to obtain your records and to create an electronic voting instruction form.
ELECTRONIC DELIVERY OF FUTURE PROXY MATERIALS
If you would like to reduce the costs incurred
by our company in mailing proxy materials, you can consent to receiving all future proxy statements, proxy cards and annual reports electronically via e-mail or the internet. To sign up for electronic delivery, please follow the instructions above
to vote using the internet and, when prompted, indicate that you agree to receive or access proxy materials electronically in future years.
VOTE BY PHONE - 1-800-690-6903
Use any touch-tone telephone to
transmit your voting instructions up until 8:59 p.m. (Pacific Time) on May 17, 2018 or the 401(k) cut-off time, as applicable. Have your proxy card in hand when you call and then follow the instructions.
VOTE BY MAIL
Mark, sign and date your proxy card and return it in the postage-paid envelope we
have provided or return it to Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717. Proxies submitted by mail must be received prior to the meeting date.
TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS:
E43054-P04607
KEEP THIS PORTION FOR YOUR RECORDS
THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED.
DETACH AND RETURN THIS PORTION ONLY
CBRE GROUP, INC.
The Board of Directors recommends you vote FOR the following proposals:
1. Elect Directors
Nominees:
For Against Abstain
1a. Brandon B. Boze
1b. Beth F. Cobert
1c. Curtis F. Feeny
1d. Christopher T. Jenny
1e. Gerardo I. Lopez
1f. Paula R. Reynolds
1g. Robert E. Sulentic
1h. Laura D. Tyson
1i. Ray Wirta
1j. Sanjiv Yajnik
For Address Changes and/or Comments, mark here (see reverse for instructions).
For Against
Abstain
2. Ratify the appointment of KPMG LLP as our independent registered public accounting firm for 2018.
3. Advisory vote to approve named executive officer compensation for 2017.
4. Approve an
amendment to our certificate of incorporation to reduce (to 25%) the stock-ownership threshold required for our stockholders to request a special stockholder meeting.
The Board of Directors recommends you vote AGAINST the following proposal:
For Against Abstain
5. Stockholder proposal regarding our stockholders ability to call special stockholder meetings.
NOTE: To transact any other business properly introduced at the Annual Meeting.
For Address
Changes and/or Comments, mark here (see reverse for instructions).
Please sign exactly as your name(s) appear(s) hereon. When signing as attorney, executor,
administrator, or other fiduciary, please give full title as such. Joint owners should each sign personally. All holders must sign. If a corporation or partnership, please sign in full corporate or partnership name by authorized officer.
Signature [PLEASE SIGN WITHIN BOX] Date
Signature (Joint Owners) Date
Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting:
The Notice and Proxy Statement and Annual Report are available at www.proxyvote.com
E43055-P04607
CBRE GROUP, INC.
Annual Meeting of Stockholders
May 18, 2018 8:30 a.m. (Eastern Time)
This proxy is solicited on behalf of the Board of Directors
The undersigned hereby appoints
Robert E. Sulentic and James R. Groch, or either of them, as proxies, each with the power to appoint his substitute, and hereby authorizes them to represent and to vote, as designated on the reverse side of this ballot, all of the shares of common
stock of CBRE GROUP, INC. that the undersigned would be entitled to vote at the Annual Meeting of Stockholders to be held at 8:30 a.m. (Eastern Time) on May 18, 2018 at 200 Park Avenue, 21st Floor, New York, New York, and any adjournment or
postponement thereof.
This proxy, when properly executed, will be voted in the manner directed herein. If no such direction is made, this proxy will be voted in
accordance with the Board of Directors recommendations. In their discretion, the proxies are authorized to vote upon such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.
Address Changes/Comments:
(If you noted any Address Changes/Comments above, please mark
corresponding box on the reverse side.)
Continued and to be signed on reverse side